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Abstract
Prostate biopsy is the clinical standard for cancer diagnosis and is typically performed
under two-dimensional (2D) transrectal ultrasound (TRUS) for needle guidance.
Unfortunately, most early stage prostate cancers are not visible on ultrasound and the
procedure suffers from high false negative rates due to the lack of visible targets. Fusion
of pre-biopsy MRI to 3D TRUS for targeted biopsy could improve cancer detection rates
and volume of tumor sampled. In MRI-TRUS fusion biopsy systems, patient or prostate
motion during the procedure causes misalignments in the MR targets mapped to the live
2D TRUS images, limiting the targeting accuracy of the biopsy system.
In order to sample smallest clinically significant tumours of 0.5 cm3 with 95%
confidence, the root mean square (RMS) error of the biopsy system needs to be <2.5 mm.
In addition to intermittent prostate motion during the procedure, prostate deformation due
to needle insertion and biopsy gun firing is a potential source of error that limits needle
targeting accuracy. Using non-rigid registration of 2D TRUS images, we quantified the
deformation that occurs during the needle insertion and the biopsy gun firing and showed
that the tissue deformation was such that throughout the length of the needle axis,
spherical tumours with radius 2.1 mm or more can be sampled with 95% confidence,
under the assumption of zero error elsewhere in the biopsy system.
The target misalignments due to intermittent prostate motion during the procedure
can be compensated by registering the live 2D TRUS images acquired during the biopsy
procedure to the pre-acquired baseline 3D TRUS image. The registration must be
performed both accurately and quickly in order to be useful during the clinical procedure.
We developed an intensity-based 2D-3D rigid registration algorithm and validated it by
ii

calculating the target registration error (TRE) using manually identified fiducials within
the prostate. We discuss two different approaches that can be used to improve the
robustness of this registration to meet the clinical requirements. Firstly, we evaluated the
impact of intra-procedural 3D TRUS imaging on motion compensation accuracy since
the limited anatomical context available in live 2D TRUS images could limit the
robustness of the 2D-3D registration. The results indicated that TRE improved when
intra-procedural 3D TRUS images were used in registration, with larger improvements in
the base and apex regions as compared with the mid-gland region. Secondly, we
developed and evaluated a registration algorithm whose optimization is based on learned
prostate motion characteristics. Compared to our initial approach, the updated
optimization improved the robustness during 2D-3D registration by reducing the number
of registrations with a TRE > 5 mm from 9.2% to 1.2% with an overall RMS TRE of 2.3
mm.
The methods developed in this work were intended to improve the needle
targeting accuracy of 3D TRUS-guided biopsy systems. The successful integration of the
techniques into current 3D TRUS-guided systems could improve the overall cancer
detection rate during the biopsy and help to achieve earlier diagnosis and fewer repeat
biopsy procedures in prostate cancer diagnosis.

Keywords: prostate biopsy, three-dimensional ultrasound, transrectal ultrasound,
prostate motion, motion compensation, image registration, 2D-3D registration,
registration optimization
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Chapter 1.
Introduction
Prostate biopsy is the clinical standard for prostate cancer diagnosis, which is a procedure
usually performed under two-dimensional (2D) transrectal ultrasound (TRUS) guidance.
Unfortunately, most early stage prostate cancers are not visible on ultrasound, so the
procedure is routinely performed in a systematic, but ultimately random fashion, where
biopsy cores are collected following a standard sextant plan with the aim of sampling any
tumors that are occult on ultrasound [1]. The procedure suffers from a false negative rate
as high as 30% due to the lack of visible targets [2]. Prostate magnetic resonance
imaging (MRI) is more sensitive to detection of small lesions and its use for pre-biopsy
target identification is rapidly growing [3-5]. With the objective of improving the cancer
detection rate during biopsy, systems have been developed to perform a targeted biopsy
by fusing pre-biopsy MRI with 3D TRUS [6-11]. In many such systems, prior to
performing biopsy, suspicious lesions delineated as targets in a pre-biopsy MR image are
mapped to the static baseline 3D TRUS image acquired at the beginning of the biopsy
session [12-15]. Biopsy is subsequently performed, targeting each suspicious lesion
using the live 2D TRUS images acquired while tracking the ultrasound probe position
and orientation relative to the baseline 3D TRUS image.
Prostate biopsy is an outpatient procedure that is performed when the patient is
awake in the lateral decubitus position under local anaesthesia. We have observed that
patient discomfort can lead to intermittent prostate motion/displacement during the
procedure. TRUS probe pressure is another source of prostate motion, when the
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physician maneuvers the probe to reach different regions within the prostate; although the
prostate is attached to the surrounding tissue, it can move as a unit within the pelvis in
response to probe pressure at different prostate locations [16]. The variability in applied
TRUS probe pressure could also deform the prostate, particularly in the posterior region.
In a targeted approach to biopsy where suspicious locations for cancer need to be
sampled, intermittent prostate motion during the procedure could limit accuracy in
maintaining the correspondence between live TRUS images and the targets defined in the
baseline 3D TRUS image. Identification of the errors due to prostate motion and the
development of accurate and fast registration methods to compensate for patient and
prostate motion during the procedure are therefore helpful to improve needle targeting
accuracy of 3D TRUS-guided biopsy systems.
The focus of this thesis is to quantify and compensate for the errors due to patient
and prostate motion during biopsy in the mechanically assisted 3D TRUS-guided biopsy
system [8] previously developed in our lab. This would help to detect clinically
significant tumours at an early stage using the emerging MR-targeted, 3D TRUS-guided
approach to performing biopsy and could impact the overall prostate cancer detection rate
from biopsy, leading to fewer biopsy sessions, earlier diagnosis, and appropriate
treatment selection. The remainder of the chapter describes the current status in prostate
cancer prevalence, the available diagnostic methods, 3D-guided biopsy systems and how
image-based registration could help improve their clinical outcomes in practice with
hypothesis and specific objectives of the thesis.
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1.1 Prostate cancer and its prevalence
Prostate cancer is the most commonly diagnosed non-skin cancer among Canadian men
contributing to 25% (~24, 000) of all estimated new cancer cases in 2013 [17]. It is also
reported to be the third largest contributor to estimated cancer deaths among Canadian
men in 2013, representing 10% of all deaths [17]. Approximately 1 in 7 men will be
diagnosed with prostate cancer during his lifetime and 1 in 37 will die of this disease.
Prostate cancer incidence increases with age, with 34% of men in their 50s and 70% of
the men at the age 80 showing histologic evidence of prostate cancer [18]. Prostate
cancer exhibits a wide variation of natural history, with the existence of clinically
indolent tumours in some men and aggressive, metastatic, lethal tumours with
considerable morbidity in others. Therefore, the ability to differentiate between indolent
and aggressive disease during the diagnosis is paramount for successful prostate cancer
management in the population.
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Figure 1.1: (a) Anatomical position of the prostate relative to the neighboring organs in a sagittal view. (b)
Primary anatomic regions of the prostate in a sagittal view.
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The prostate in a healthy adult male is a walnut sized organ, approximately 20
cm3 in volume, sitting on the pelvic floor, surrounding the urethra, and proximal to the
bladder neck (Figure 1.1(a)). The base, the mid-gland and the apex constitute the three
primary anatomic regions of the prostate (Figure 1.1(b)). The superior region of the
prostate proximal to the bladder neck is identified as the base, while the inferior region
proximal to the urogenital diaphragm is identified as the apex. The prostate has also been
divided anatomically into four different lobes: (1) anterior lobe, (2) posterior lobe, (3)
lateral lobes, and (4) median lobe. McNeal [19-21] proposed a zonal model, which is
widely used in pathology, to describe prostate glandular anatomy, dividing the prostate
into three distinct zones: (1) central zone; (2) peripheral zone; and (3) transition zone
(Figure 1.2). The central zone (CZ) is a wedge-shaped volume containing about 25% of
the glandular tissue of the prostate, in the region between the bladder neck to
verumontanum. The peripheral zone (PZ) is the largest zone lying distal to the central
zone containing about 70% of the glandular tissue within the prostate. The transition
zone (TZ) comprises 5% to 10% of prostate glandular tissue lying on either side of the
urethra just above the ejaculatory duct openings. The anterior fibromuscular stroma (AZ)
is another portion consisting of approximately one-third of the prostate organ. It is
composed of non-glandular tissue [21], although some consider it to be the fourth zone
[22].
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Figure 1.2: Central zone (CZ), peripheral zone (PZ), transition zone (TZ), anterior fibromuscular stroma
(AZ) constituting the zonal anatomy of the prostate in a sagittal view.

Most men tend to have some enlargement of the prostate with aging, sometimes
causing a common urologic condition known as benign prostatic hyperplasia (BPH). This
enlargement affects primarily the transition zone, occurring above the level of
verumontanum. Since the prostate wraps around the urethra, prostate enlargement can
obstruct the flow of urine. Therefore, urinary obstructive symptoms such as urinary
retention, frequent urination and nocturnal voiding are possible with BPH patients.
However, BPH patients do not show increased risk of developing prostate cancer [23].
BPH is not the only cause of prostate growth in aging men. Prostate cancer
tumours could cause growth and create hard nodules within the prostate. Prostate cancers
can be multi focal, and about two thirds are found in the peripheral zone, causing an
asymmetric growth of the prostate. Unlike BPH, however, early stage prostate cancers
are asymptomatic, making timely diagnosis very challenging. Although current
understanding of what causes prostate cancer is limited [24], endogenous factors such as
age, family history and ethnicity have shown association with cancer risk [25].
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1.2 Prostate cancer diagnosis
1.2.1 Digital rectal examination (DRE)
Early detection of prostate cancer is critical to devise successful treatment methods in
order to reduce morbidity and mortality. Since early stage prostate cancer is
asymptomatic, there are screening tests advocated with the goal of improving diagnostic
outcomes among the average to high-risk population. Digital rectal examination (DRE)
is the first screening method introduced as early as in 1905, in which the physician
palpates the prostate with a gloved finger inserted into the patient’s rectum. The
physician examines for discrete hard nodules, prostate asymmetry and firmness as
characteristics that are suspicious for cancer. Although this is an easy, inexpensive test, it
suffers from poor sensitivity with cancer detection rates < 50%, missing most early stage
tumours [26]. Most cancers were detected at an advanced stage with this method and the
diagnostic decisions were prone to high inter-examiner variability [27].

1.2.2 Prostate specific antigen (PSA) test
The serum level of prostate specific antigen (PSA) in the blood is another screening test
introduced in the late 1980s. The probability of cancer increases with concentration of
PSA in blood, with the most commonly used threshold being 4 ng/ml for prostate cancer
detection. Although PSA has high sensitivity for cancer detection, the PSA level in the
blood can increase due to conditions unrelated to cancer, such as BPH, infection or
inflammation, resulting in poor specificity of the test [28, 29]. Although the use of PSA
screening since 1985 has impacted the patterns in cancer incidence and mortality [30], the
poor sensitivity of screening tests for detecting cancer and the challenges in
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differentiating between indolent and aggressive disease could potentially result in
overdiagnosis and overtreatment. Currently, the American Cancer Society recommends
that average-risk, asymptomatic men at age 50 to make an informed decision with the
physician to be screened for prostate cancer [31].

The clinical standard for definitive

diagnosis of prostate cancer is prostate biopsy.

1.2.3 Prostate biopsy
Patients with elevated PSA or abnormal DRE are referred to prostate biopsy. Needle
biopsy remains the clinical standard for prostate cancer diagnosis, a procedure performed
with the objective of detecting aggressive tumours that could cause potential harm. It is
an outpatient procedure conventionally performed using 2D transrectal ultrasound
(TRUS) guidance. It is usually performed when the patient is in left lateral decubitus
position with local or topical anesthesia. The physician samples tissue locations following
a sextant template biopsy scheme using a spring-loaded 18-gauge biopsy needle. Several
systematic biopsy schemes have been proposed [1, 32, 33] and usually 6-12 biopsy cores
are taken during the procedure under these schemes. The tissue samples are then
processed and examined by urological pathologists in search for any histological
abnormalities and to assess the severity and extent of the disease.
Assessing the extent of the disease is a vital component before devising
appropriate treatment methods. The most commonly used method to categorize the
disease extent is the TNM staging system [34]. According to this scheme, cancer is
classified into four major stages (T1 – T4) evaluating three main areas: (1) primary
tumour, (2) metastatic disease, and (3) involvement of nearby lymph nodes. Table 1.1
shows the diagnostic criteria for classification of the different stages of cancer. Prostate
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biopsy results, prostate cancer imaging and manual palpation of the prostate could aid in
determining the disease stage during diagnosis. TRUS has been the conventional and
most widely used imaging modality in examining the extent of hypoechoic regions in the
prostate for suspicion of cancer [35]. However, MRI has recently shown promise, with
improved sensitivity (73-86%) and specificity (77-94%) in determining cancer stage [36,
37].
Table 1.1: TNM staging of prostate cancer
Stage
T1
T2
-T2a
-T2b
-T2c
T3
T4

Criteria
Tumour at incidental stage, but impalpable and not detectable by imaging
Locally confined palpable tumour
Tumour exists in half or less than half of one of the two lobes
Tumour exists in more than half of only one lobe
Tumour exists in both the lobes
Tumour has spread through the prostatic capsule
Tumour has invaded to other neighboring organs

In measuring the severity of prostate cancer, the Gleason grading system [38] is
the most widely accepted and commonly used method. In this system, the glandular
pattern of the tumour in biopsy cores is identified and assigned a grade from 1 to 5 at a
relatively low magnification level. The scoring is based on the differentiation of prostate
cancer cells, with 1 the most differentiated and 5 the least differentiated. Both the
primary tissue grade – score given to the most prevalent pattern containing the tumour –,
and the secondary grade – the score given to the second most prevalent pattern
containing the tumour – are assessed independently and summed to get the overall
Gleason score. Thus, the Gleason score can range from 2 (1+1) to 10 (5+5), with 2 being
the lowest grade given to insignificant disease and 10 being the highest grade given to
advanced disease. A Gleason score of 7 (4 +3) indicates that the patient has the most
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common glandular pattern with a score 4 and the second most common pattern with a
score 3. A Gleason score of 7 (4 + 3) is less desirable than a score of 7 (3 + 4), since the
most common glandular pattern is less aggressive in the latter.
Based on the results of PSA, staging and grading, cancer patients can be classified
into three risk groups [39-41]. According to the classification by D’Amico et al. [41],
patients with Gleason score 8-10, stage ≥T2c or PSA >20 ng/ml are considered high risk,
with aggressive tumours and advanced disease. While these patients are not
recommended for localized therapy, the typical treatment options are radical
prostatectomy and external beam radiotherapy. Patients with Gleason score 7, stage T2b
or PSA 10.1-20 ng/ml are considered to be intermediate risk. These patients with organ
confined disease are amenable to be treated with localized treatment methods such as
focal laser ablation and high intensity focused ultrasound. On the other hand, the patients
with Gleason score 2-6, stage T1-T2a, and/or PSA <10 ng/ml are considered to be low
risk and clinically insignificant.
The prostate biopsy results play a critical role in differentiating between
aggressive and indolent disease and in selecting treatment options for tumours that need
attention. While underdiagnosis and undertreatment of aggressive cancers could cause
lethal effects on patients, overdiagnosis and overtreatment could lead to undesirable
health outcomes like urinary incontinence and erectile dysfunction. Unfortunately, the
“blind” approach to systematic prostate biopsy has high false negative rates in the range
10-30% [32, 42-44], leaving uncertainty in the generated results during its role as the
diagnostic tool for prostate cancer. As a consequence, clinicians have to base their
decisions on evidence that is inconclusive and repeat biopsies might need to be
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performed to increase the certainty of the diagnosis. For example, an increasing trend in
PSA level could lead to repeat biopsy in patients who have already undergone prior
negative biopsies. Patients who underwent a second biopsy session have reported cancer
detection rates of 19%, [45] indicating the limitations of the conventional systematic
biopsy scheme. In order to improve the cancer detection rates, saturation biopsy schemes
have been proposed by increasing the number of biopsy cores to the range 15-31 [46-48].
However, the high probability of these schemes to detect clinically indolent cancers,
increased cost and morbidity have limited their adaptation as the mainstay approach to
biopsy in comparison to the sextant approach with 6-12 cores. In fact, a subsequent
prospective study [49] reported no significant difference in terms of cancer detection rate
in saturation and sextant approaches.

1.3 Prostate cancer imaging
1.3.1 Ultrasound imaging
Ultrasound evaluation of the prostate could be achieved via transabdominal, transrectal or
transperineal access. TRUS is the most common approach used in prostate examinations
to detect pathology and calculation of prostate volume [50]. The transrectal approach
provides better access to peripheral zone tumours in prostate posterior, where 70-80% of
the prostate cancers arise [51] and improves the ability to direct needles into regions of
interest during biopsy procedures.
A transducer containing transmitting elements, electrodes, and protective face
generates ultrasound waves [52]. High frequency ultrasound transducers within the range
5-10 MHz are used for TRUS imaging. Commercially available TRUS probes are either
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side-firing or end-firing, with end-firing probes more suitable for image guidance during
trans-rectal prostate biopsy [53]. Some probes come with enhanced functionality to
simultaneously acquire dual-orthogonal (transverse and sagittal) planes or full 3D
imaging. While the acquisition rate is 10-20 frames per second using single-plane 2DTRUS probes, 3D image acquisition could take up to 5 s using enhanced probes.
Ultrasound waves are reflected as they penetrate through different tissues and
anatomical structures. The degree of reflectance depends on the acoustic impedance
between two layers of tissue. Structures that reflect most of the ultrasound waves appear
as bright regions in images while the structures that reflect the least appear as dark
regions. Relative to the medium-gray echogenicity of the peripheral zone, structures that
appear brighter are termed hyperechoic and those that appear darker are termed
hypoechoic. The pubic bone and prostatic calcifications are examples of hyperechoic
anatomical structures that appear bright on ultrasound. On the other hand, fluid-filled
structures like seminal vesicles, vas deferens, ejaculatory ducts, cysts, and the gall
bladder appear hypoechoic in ultrasound. Figure 1.3 shows examples of the appearance
of a calcification and a cyst in 2D TRUS images. The boundaries between zonal
anatomical structures can often be identified in ultrasound images as hypoechoic linear
demarcations. Prostate cancer in the peripheral zone is typically considered to appear as
hypoechoic on TRUS [54], while transition zone cancers have shown more heterogeneity
in appearance. However, elusive nature of cancer appearance in TRUS has posed many
challenges in using it as an imaging modality to detect suspicious regions for prostate
cancer [55, 56] and has been reported with low sensitivity (35-91%) and specificity (2481%) values in prostate cancer screening [57-61].
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(b)

(a)

Figure 1.3: The appearance of (a) a calcification, and (b) a cyst in a 2D TRUS image.

With the objective of improving cancer detection using ultrasound imaging
modality and providing guidance to suspicious target regions during biopsy, several
enhanced techniques have been investigated. Color and power Doppler ultrasound
imaging has been applied to evaluate blood flow and vascularity within the prostate tissue
[62, 63]. Due to the formation of new vessels in tumours, cancerous tissues tend to
demonstrate hypervascularity [64]. Contrast-enhanced ultrasound (CEUS) is another
approach to improve tumour visibility in imaging where encapsulated gas microbubbles
are injected into the small vessels to improve their ultrasound reflectivity in highly
vascular regions formed potentially due to cancer [65, 66]. Elastography is another
ultrasound-based imaging technique that is currently being investigated to detect tumours
using mechanical properties of tissues. Since the tissue stiffness properties differ in
cancerous tissues, elasticity imaging techniques could potentially be used to identify them
in real time [67].

Although some of these ultrasound-based imaging methods are the

subject of active research, the benefits of such approaches in improving clinical outcomes
over systematic biopsy have not yet been proven [68, 69].
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1.3.2 Computed tomography (CT) and nuclear imaging
Other modalities like CT, positron emission tomography (PET) and single photon
emission computed tomography (SPECT) have been used to image the prostate.
However, their use has been primarily focused on radiotherapy planning and prognostic
evaluation of metastatic disease. CT images are sometimes acquired for the purpose of
determining the cancer stage when it has spread at a macroscopic level to the perineal
floor and lymph nodes [70], but are rarely acquired for primary prostate evaluation.
Similarly, PET and SPECT imaging are used in identification of metastatic spread of
cancer to the bones.

1.3.3 MR imaging
Although moderate staging performance was observed for images obtained from early
MR scanners [71], with recent improvements in signal-to-noise ratio and image quality
[72], multi-parametric MR images have shown promise in detecting and localizing
prostate cancer. T1-weighted imaging has been demonstrated to be useful in TRUSguided biopsy hemorrhage artifact detection, but has limited use in prostate cancer
imaging due to low contrast. T2-weighted MR is the most widely used sequence for
prostate cancer imaging and it can clearly differentiate the prostate zonal anatomy. On
T2-weighted images, the typical peripheral zone has high-signal intensity, greater than
nearby structures [73]. In prostate cancer, the loss of normal glandular morphology tends
to cause regions with low-intensity level. Benign conditions like BPH typically have a
nodular appearance on T2-weighted imaging; however, loss of glandular morpohology
can also cause BPH to appear as a low-intensity signal. Due to these confounding
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factors, prostate cancer detection using T2-weighted imaging alone could be challenging
[74]. However, different functional MR techniques can be used in combination to
improve the differentiation of cancerous tissue.
Diffusion-weighted MR imaging is a functional imaging technique in which
proton diffusion properties in water are used to generate image contrast by quantifying
the average random motion of hydrogen nuclei within the body. The apparent diffusion
coefficient (ADC) quantifies the direction and distance of water molecules due to both
perfusion and diffusion within the interpulse time of an applied motion-encoding gradient
in MR that cause proton movements and phase shifts. Healthy prostate peripheral zone
tissue contains tubular structures that allow abundant diffusion of water molecules in
these regions, resulting in high ADC values. Prostate cancer, in contrast, tends to destroy
the tubular structures and replace ducts often showing lower ADC values when compared
with healthy prostate tissue [75, 76]. However, conditions like BPH and prostatitis could
result in lower ADC values, which could limit the ability to make a definitive diagnosis
using this information alone [77, 78].

(a)

(b)

(c)

Figure 1.4: Multiparametric MR images of the prostate with suspicious region for cancer indicated by the
yellow arrow: (a) T2-weighted image showing a region with hypo intensity. (b) DCE image not showing
any contrast for this patient in the suspicious area. (c) ADC map showing a region of hypointensity.
14

Dynamic contrast-enhanced (DCE) MR imaging is another functional imaging
method to aid in the detection of cancerous regions by noninvasively examining tumor
angiogenesis. It consists of a series of T1-weighted images acquired successively after
injection of a gadolinium contrast agent to evaluate tumour vascular function. Since
prostate cancer tumours are highly vascular, a comparison of pre- and post-gadolinium
images could be used to identify regions suspicious for prostate cancer [79]. When
compared with healthy tissue, prostate cancer tends to show rapid wash-in and wash-out
with the contrast agent injection [80]. Magnetic resonance spectroscopy imaging (MRSI)
[81], MR elastography [82] and sodium imaging [83] are some other emerging
techniques that have the potential to aid prostate cancer detection via imaging.
Developing mechanisms for prostate cancer detection and localization is a nontrivial task considering the biological and pathological complexity of the disease.
Although different MR imaging sequences have their strengths and limitations,
combination of different techniques could help to mitigate the limitations of individual
sequences and help improve the accuracy in making a definitive diagnosis. Figure 1.4
shows the appearance of a suspicious cancer region of a patient in T2-weighted, DCE and
DWI images. The European Society of Urogenital Radiology (ESUR) has recently
published a report [84] providing guidelines for MRI of prostate cancer based on
published evidence and expert opinion. This report recommends the use of a combination
of high-resolution T2-weighted images and at least two functional MRI techniques when
detecting cancer with a multiparametric MRI examination. The guidelines also include a
structured scoring system (Prostate Imaging and Reporting Data System [PI-RADS]) for
classification and reporting of tumours during the diagnosis. While the clinical protocols
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using multiparametric MRI for prostate cancer are becoming standardized, currently
active research is focused on investigation of MR to histopathology correlation to further
improve the detection of cancer using in vivo imaging [85-88]. Although currently
reported sensitivity (73-86%) and specificity (77-94%) results [89-91] for prostate cancer
detection in MR imaging does not permit replacement of needle biopsy as the clinical
standard of diagnosis, multi-parametric MR has the potential utility in guiding biopsy
towards target regions and subsequently could be used in conjunction with biopsy results
to make informative assessment during staging and grading of cancer. Detecting cancer
using in vivo imaging is also beneficial in contouring tumours for localized treatment of
intermediate-risk prostate cancer.

1.4 3D-guided prostate biopsy systems
While the standard sextant approach to prostate biopsy under 2D TRUS-guidance usually
lacks visible tumour targets, multi-parametric MRI has shown promise in non-invasive
detection of cancer. The addition of the MR-detected cancer suspicious regions as targets
during biopsy could impact and improve the limited sensitivity and specificity of the
conventional sextant template schemes. Aligning the biopsy needle trajectories with the
regions identified in MR requires accurate localization of target locations within the 3D
anatomy of the prostate. In order to achieve this objective, the physician could initially
identify the target locations in MR and then mentally map those locations into the space
of intra-procedural TRUS imaging for targeting. Such an approach to performing biopsy
with cognitive MR-TRUS fusion can be implemented with existing conventional 2D
TRUS-guided biopsy systems, eliminating the need for the development and integration
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of additional hardware and/or software components [92]. However, previous studies [15,
93, 94] have not shown convincing results in terms of improvement in cancer detection
rates with this approach in comparison to random systematic biopsy. In addition, a
cognitive fusion of images of two modalities is, in principle, operator dependent and
needle targeting accuracy is likely to be correlated with the 3D cognitive spatial skills and
experience level of the physician with this task. Moreover, rotational symmetry and the
limited discrete anatomical landmarks of the prostate available in 2D TRUS images could
pose challenges in accurate localization of the target locations in 3D. Thus, the
anatomical and spatial context achieved with conventional 2D TRUS guidance alone
might not yield the desired level of accuracy to guide needles to successfully sample
tissue from target locations.
With the objective of improving needle targeting accuracy during biopsy, systems
[6, 8, 95, 96] have been developed to provide 3D guidance during biopsy. In addition to
providing a richer 3D context within which to guide biopsy needle insertion, these
systems can record and archive biopsy locations in 3D. These archived locations could
assist in determining the biopsy target locations if repeat biopsies are required either to
avoid targeting previously sampled locations or to take a sample closer to a previously
biopsied location. MR-identified target locations have been mapped to the intraprocedural imaging space using two major approaches in the emerging 3D-guided biopsy
systems: (1) direct MR-guided biopsy systems, and (2) MR-TRUS fusion biopsy systems.

1.4.1 Direct MR-guided biopsy systems
There are multiple systems [97] developed that are capable of acquiring MR images
directly during the procedure for guidance and recording of biopsy locations in 3D. In
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these systems, the patient usually lies in the prone position and the needles are inserted
via either transrectal or transperineal access. Some of the systems have been designed to
perform the MR-guided biopsy in an open bore [98-100], while some others perform the
biopsy in a closed bore [95, 101, 102]. Although open bore systems have less confined
space during needle manipulation, the image quality is poor due to the use of low field
magnets. On the other hand, although closed-bore MR scanners can generate superior
image quality for better guidance, the confined space inside the bore could pose
challenges in tool design and manipulation. During the typical workflow in these
systems, suspicious target delineation is performed using a previously acquired
diagnostic MR image prior to the procedure, and identified locations are mapped to the
intra-procedural imaging space and verified using serial MR scans acquired immediately
prior to needle placement. Ultrasound images are not acquired with these systems, and
the ability to perform the biopsy using a single image modality eliminates complications
arising when fusing data between two modalities. Although there has been previously
published work [103] suggesting improved cancer detection rates with this approach,
there are several disadvantages limiting its mainstream use as a standard tool for prostate
cancer diagnosis. In-bore biopsy procedures have been reported [95] to require more
than an hour and the patient is usually sedated using general anaesthesia. Lengthy MR
scanner time and patient recovery times could impose a huge cost burden on the
healthcare system, considering the large number of biopsies that needs to be performed in
a given year. However, this approach, if proven to have superior targeting accuracy,
could be amenable to be used in patients who have to undergo multiple repeat biopsies
sessions due to previously inconclusive biopsy results. This approach is also valuable to
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MRI-histology correlative research studies, since an MR image can be acquired with the
needle in place, allowing for a spatial record of the location of this histologic sample
within the coordinate system of the MR image.

1.4.2 MR-TRUS fusion biopsy systems
Mapping of MR targets to TRUS image space via software-based image fusion is the
other major approach to 3D-guided biopsy system design. During the clinical workflow
in these systems, the diagnostic MR image is typically acquired on a day prior to biopsy
to identify suspicious lesions for cancer. These targets are then mapped to a baseline 3D
TRUS image acquired immediately prior to performing the biopsy via MR to 3D-TRUS
image registration. The co-registration of the MR and 3D TRUS images needs to be
performed using a non-rigid transformation to account for the differences in prostate
deformation due to pressures exerted from the endorectal coil (if used during MR image
acquisition) or alternatively, the lack of pressure from the body coil, and the manually
held TRUS probe in the 3D TRUS image acquisition [104, 105]. Live 2D TRUS images
are typically acquired during the biopsy procedure for real-time image guidance. The
correspondence between live 2D TRUS and the baseline 3D TRUS images, into which
the MRI targets have been mapped, is established via tracking of the TRUS probe’s
position and orientation in space. During the procedure, the physician is able to see a
visualization interface that displays the MRI-identified target locations and relative
TRUS probe positions and orientations in a 3D context. Thus, in this approach, tumour
locations identified from MRI are ultimately targeted with the aid of 3D TRUS image
guidance. Hence, the complementary advantages of high soft tissue contrast in MRI and
real-time, less expensive TRUS imaging, can be exploited to build an economically
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feasible solution with the aim of improving clinical outcomes of prostate cancer
diagnosis. In addition, this enables the prostate biopsy to be still performed as an
outpatient procedure under local anesthesia, similarly to the conventional 2D TRUSguided biopsy procedure. Software tools, that accurately co-register MR targets with the
baseline 3D TRUS image and intraprocedural TRUS imaging, are thus an essential
component to the success of this approach.
Table 1.2: A comparison of some commercially available 3D TRUS-guided biopsy systems.
System

Needle access

US probe type

Uronav (In Vivo,
USA)
Artemis (Eigen,
USA)
Urostation
(Koelis, France)

Transrectal

2D TRUS

Transrectal

2D TRUS

Transrectal

3D TRUS

Biopsee (Pi
Medical, Greece)

Transperineal

Bi-plane TRUS

US probe
tracking
Magnetic tracking
Mechanical
articulated arm
Image-based
tracking
Mechanical
stepper

Initial 3D US
image acquisition
Free hand axial
sweep
Rotational sweep
Panoramic image
from 3 volume
acquisitions
Rotational sweep

There are several solutions developed with different hardware and software
designs to provide image guidance for accurate needle targeting using a MR-TRUS
fusion approach. Table 1.2 contains a comparison of some commercially available
systems showing the approach to image acquisition, tracking and needle placement in the
different designs. While some systems are designed to retrofit existing 2D TRUS probes,
others utilize TRUS probes with enhanced functionality that can simultaneously acquire
bi-plane of full 3D imaging. In systems that use conventional 2D TRUS probes, a 3D
TRUS image is acquired at the beginning of the procedure via rotational or translational
sweep of the 2D TRUS probe, followed by a reconstruction of the resulting 2D planes to
obtain a 3D image. Although enhanced 3D TRUS probes can be more convenient during
3D image acquisition, the ability to retrofit existing ultrasound systems could be a
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desirable feature in translating the technology to the widespread clinical use due to the
potential to leverage the substantial investment in existing equipment. Accurate and
reliable TRUS probe tracking is essential to facilitate 3D guidance in these systems. The
Uronav system is equipped with electromagnetic (EM) tracking using an external
magnetic field generator and a freehand TRUS probe [10]. The major disadvantage of
EM tracking systems is the disruptive influence on tracking arising from potential
interference from nearby metal devices in the biopsy environment. The system proposed
by Bax et al. [8] uses a mechanically articulated arm to track the motion of the probe
during the procedure. While this system provides mechanical stabilisation of the probe, it
also supports locking of all joints during 3D initial image acquisition permitting only
axial probe rotation. This design is aimed to minimize prostate motion while the 3D
image is being acquired, thus minimizing errors during 3D image reconstruction. The
system proposed in [6] performs an image-based tracking that completely relies upon the
information contained within the image acquired using a specialized probe that can
simultaneously reconstruct a 3D volume. Eliminating the hardware tracking devices is a
major advantage of this system to come with a compact design. However, this system
requires a specialised 3D TRUS imaging system to acquire rich 3D information for
tracking purposes.

1.5 Challenges in 3D-guided biopsy systems
In order to achieve accurate cancer detection, the 3D-guided biopsy system needs to
accurately sample tissues from the smallest clinically significant tumours. There is a
debate in the clinical community regarding the size of the smallest clinically significant
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tumour. Epstein et al. [26] suggested a minimum significant prostate tumour volume of
0.5 cm3 and we refer to this work when discussing the desired level of accuracy in biopsy
systems. Assuming we have correctly identified and delineated tumours on MR imaging,
there are several potential sources of error that limit 3D-guided biopsy systems in
achieving a level of accuracy that allows for needle targeting with high confidence: (1)
MR-TRUS co-registration errors, (2) tracking errors in the system, (3) imaging and
calibration errors, and (4) errors due to patient and prostate motion/displacement during
the procedure. Quantification and minimization of these errors are essential to improving
the needle targeting accuracy in 3D biopsy systems. The errors due to sources (1)-(3)
have been previously quantified and mitigated [8, 105] in the context of the
mechanically-assisted 3D TRUS-guided biopsy system described in [8].
Prostate motion/deformation can cause target misalignment during 3D TRUSguided biopsy [106]. Since the patient is awake and under local anesthesia, he can move
due to discomfort during procedure, which is approximately 15 minutes in duration. The
TRUS probe pressure applied while the physician navigates the probe to different regions
of the prostate is another potential cause of prostate motion. The needle insertion and
biopsy gun firing procedure could also cause some additional motion. These motions
during the procedure can disrupt the correspondence between live 2D TRUS images and
the targets defined in the coordinate system of the baseline 3D TRUS image, causing
target misalignments and needle targeting errors. Studying prostate motion during biopsy
and finding methods for motion compensation is critical to improving the needle
targeting accuracy of 3D TRUS-guided biopsy systems.
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Recent clinical studies [12, 14, 107, 108] comparing 3D versus 2D systematic
TRUS-guided biopsies have demonstrated evidence suggesting that prostate cancer
detection rates improve with a 3D-guided approach. However, evidence from previous
work [109] analysing prostate motion during biopsy suggests that misalignments due to
motion can cause substantial errors > 5 mm relative to the clinically significant tumour
sizes reported in the literature [26, 110]. Therefore, improving needle targeting accuracy
of biopsy systems could help to further improve cancer detection rates of the 3D TRUS
guided approach and strengthen the confidence in diagnosing low to intermediate risk
cancer. Automatic localization of corresponding anatomical landmarks within the
anatomy is one potential approach to track motion during biopsy. Surface-based
registration algorithms are an example where the segmentation of the prostate boundary
can be used to achieve correspondence. While this approach relies upon an accurate,
automatic segmentation algorithm of the prostate, developing such an algorithm that is
sufficiently robust can be a challenging task in ultrasound images. Therefore, using the
image intensity information could lead to more robust image registration solutions and
simplify the workflow by eliminating the need for prostate segmentation. Development
and successful clinical translation of rapid image intensity-based registration methods to
compensate for misalignments due to prostate motion is an indispensable step towards
improving targeting accuracy to enable sampling of clinically significant tumours during
prostate biopsy.
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1.6 Image-based registration techniques
Image registration is the process of transforming multiple images to spatially align them
in a single coordinate system. In image-based registration, the alignment is achieved
using the information in image signal intensities. A quantitative measure that reflects the
desirable properties of a good alignment is defined as the objective function, and can
comprise of an image similarity metric and a regularization term. For rigid registration
applications, the objective function is typically the image similarity metric. One image is
transformed, interpolated and compared with the other image to calculate the imagesimilarity metric. In a rigid, affine or non-rigid transformation space, optimization
techniques are utilised to find the optimum metric value in an efficient manner. Thus, the
registration framework constitutes of multiple components: (1) image similarity metric,
(2) optimization technique, (3) transformation (e.g., rigid, affine or non-rigid), and (4)
interpolator. These components need to be specified in developing the image-registration
technique.
Live 2D TRUS images acquired during the procedure need to be co-registered
with the baseline 3D TRUS image acquired at the beginning of the procedure to
compensate for motion during the biopsy session. The development of accurate and fast
2D-3D registration methods could be challenging due to the limited information available
in the live 2D TRUS image. In solving uni-modality registration problems [10], the
sum-of-squared difference (SSD) and normalized cross-correlation (NCC) could be
suitable image similarity metrics. While SSD assumes the same level of image intensity
at homologous pixels in the two images, NCC tolerates a linear relationship in intensities.
Therefore, NCC is invariant to the changes in intensity scaling and shift. These metrics
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can be inherently parallelized to achieve high-speed implementations to be useful for
clinical application. The capture range of the metric is another important consideration
when selecting a useful metric. If the metric has a wide capture range within the
transformation space, large misalignments can be compensated using local optimizers to
successfully converge at the desired solutions.
Since brute-force searching of the transformation space is intractable due to
registration time requirements, the optimization technique is an essential component of
the registration algorithm to traverse the transformation space in an efficient manner.
While local optimization techniques are widely used in registration problems that have
convex, quasi-convex or monotonic objective function landscapes [111], some methods
in the literature [112, 113] have investigated the development of global optimization
techniques to improve registration accuracy and robustness. Multi-start [114], simulated
annealing [115], particle swarm [116], genetic [117] approaches have been used in
registration problems with the objective of improving robustness. However, this could
lead to an increase in computation times due to the increase in the number of image
similarity metric evaluations and slower convergence properties. Efficient
implementation of optimization algorithms using graphics processing units (GPU) [113]
and development of algorithms with improved convergence properties [118] could be
helpful in adopting such algorithms for applications that require rapid registration.
The properties of some optimization techniques can be more desirable in
achieving high speed performance in principle. Multiple local optimization techniques
(e.g., Newton’s method, quasi-Newton method, conjugate gradient method, Powell’s
method) developed over the years are derived from a quadratic model and have quadratic
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convergence properties. These methods assume and approximate second order
characteristics of the function within its local neighborhood and are capable of finding
the optimum of the function in a finite number of function/derivative evaluations given a
reasonable satisfaction of the quadratic model assumption. This is a useful property that
aids fast convergence when optimizing a multi-dimensional function in image
registration. Techniques that rely on first order properties of the function (e.g., gradient
descent/steepest descent [119, 120]), on the other hand, have linear convergence
properties. There is another classification of optimization methods based on whether the
calculation of the objective function’s derivative is required. Some optimization methods
(e.g., conjugate gradient method, Newton’s method) explicitly calculate the derivative of
the objective function, while some others (e.g., Powell’s method [121], CMA-ES method
[122]) are derivative-free and the optimization is achieved using only function
evaluations. Derivative-free methods can be useful if the explicit calculation of the
function derivative is either time consuming or not straightforward.

1.7 Image registration accuracy required for the clinical application
The work in this thesis is focused on the errors due to prostate motion that limit the
biopsy system in achieving the desired targeting accuracy, but had not been previously
quantified and mitigated from the potential sources of error that we have enumerated in
section 1.5. Given that the suspicious tumour locations have been identified in the
baseline 3D TRUS image, errors due to intermittent patient and prostate
motion/displacement during the procedure and due to prostate deformation during the
needle insertion and the biopsy-gun firing could challenge the accurate targeting of those
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locations using a 3D TRUS-guided biopsy system. On the other hand, there is evidence
suggesting that tumours > 0.5 cm3 are clinically significant [26, 110]; such tumours have
a radius of 5 mm under the spherical assumption. In order to accurately target a 5 mm
radius spherical tumour with 95% probability, the root mean square (RMS) error of the
biopsy system should be ≤ 2.5 mm.

1.8 Hypothesis
The central hypothesis is that image-based 2D-3D registration of TRUS images can
correct for intermittent prostate displacement during the biopsy procedure, with an RMS
target registration error (TRE) ≤ 2.5 mm.

1.9 Objectives
To test the central hypothesis, the four major objectives of this thesis work are:
I.

To quantify the prostate motion and deformation due to needle insertion and
biopsy-gun firing procedure and calculate the 95% prediction interval around the
tissue deformation and compare this deformation in handheld and mechanicallyassisted systems.

II.

To (a) develop a 2D-3D registration technique with sufficient accuracy and speed
for prostate motion compensation during biopsy, and (b) validate this registration
method retrospectively using live 2D TRUS images and baseline 3D TRUS
images acquired during human clinical biopsy procedures using a mechanicallyassisted 3D TRUS-guided biopsy system [8].

III.

To (a) evaluate the utility of intra-procedural 3D TRUS images in guiding
registration during motion compensation to robust solutions, (b) identify the
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anatomical regions that benefit the most from such additional intra-procedural 3D
information, and (c) test whether a robust rigid registration is sufficient to achieve
clinically desired level of accuracy.
IV.

To (a) improve the robustness of registration optimization using learned
characteristics from observed prostate motion data, (b) measure the major patterns
of prostate motion during biopsy, and (c) modify Powell’s direction set method
initialization to incorporate learned motion characteristics.

1.10 Thesis outline
1.10.1 Chapter 2 - Quantification of prostate deformation due to needle
insertion during TRUS-guided biopsy: Comparison of hand-held and
mechanically stabilized systems
In this chapter, we describe our work to quantify the deformation that occurs during the
needle insertion and the biopsy-gun firing procedure using non-rigid registration of 2D
TRUS images acquired during human clinical biopsy procedures. We calculated the
spatially varying 95% confidence interval on the prostate tissue motion and analysed this
motion both as a function of distance to the biopsy needle and as a function of distance to
the lower piercing point of the prostate. The former is relevant because biopsy targets lie
along the needle axis, and the latter is of particular importance due to the reported high
concentration of prostate cancer in the peripheral zone, a substantial portion of which lies
on the posterior side of the prostate where biopsy needles enter the prostate after
penetrating the rectal wall during transrectal biopsy.
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The results showed that for both systems, the tissue deformation is such that
throughout the length of the needle axis, including regions proximal to the lower piercing
point, spherical tumours with radius 2.1 mm or more can be sampled with 95%
confidence, under the assumption of zero error elsewhere in the biopsy system. More
deformation was observed in the direction orthogonal to the needle axis, compared to the
direction parallel to the needle axis; this is of particular importance given the long,
narrow shape of the biopsy core. We measured lateral tissue motion proximal to the
needle axis of not more than 1.5 mm, with 95% confidence. We observed a statistically
significant, but clinically insignificant maximum difference of 0.38 mm in the
deformation resulting from the hand held and mechanically assisted systems along the
needle axis, and the mechanical system resulted in a lower relative increase in
deformation proximal to the needle axis during needle insertion, as well as lower
variability of deformation during biopsy gun firing.

1.10.2 Chapter 3 - 2D-3D rigid registration to compensate for prostate
motion during 3D TRUS-guided biopsy
The error due to needle insertion and biopsy gun-firing procedure, described in Chapter
2, occurs during a very short period of time and is challenging to compensate.
Intermittent patient and prostate motion cause larger misalignments [109] challenging the
needle targeting accuracy to meet this requirement. To compensate for this motion, we
implemented and tested an intensity-based 2D-3D rigid registration algorithm optimizing
the NCC using Powell’s method. The 2D TRUS images acquired during the procedure
prior to biopsy gun firing were registered to the baseline 3D TRUS image acquired at the
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beginning of the procedure. The accuracy was measured by calculating the TRE using
manually identified fiducial markers (henceforth fiducials) within the prostate for eight
patients. These fiducials were used for validation only and were not provided as inputs to
the registration algorithm. We also measured the accuracy when the registrations were
performed continuously throughout the biopsy procedure by acquiring and registering
live 2D TRUS images every second. This measured the improvement in accuracy
resulting from performing the registration continuously compensating for motion during
the procedure. To further validate the method using a more challenging data set from 10
patients, registrations were performed using 3D TRUS images acquired by intentionally
exerting different levels of ultrasound probe pressures in order to measure the
performance of our algorithm when the prostate tissue was intentionally deformed. In
this data set, biopsy scenarios were simulated by extracting 2D frames from the 3D
TRUS images and registering them to the baseline 3D image. A GPU-based
implementation was used to improve the registration speed. We also studied the
correlation between NCC and TREs.
With the GPU based implementation, the registrations were performed with a
mean time of 1.1 s. The TRE values before, during and after registration showed a weak
correlation (r2 = 0.23) with the similarity metric. However, we measured a generally
convex shape of the metric around the ground truth registration, which may explain the
rapid convergence of our algorithm to accurate results. The RMS TRE of registrations
performed prior to biopsy gun firing was found to be 1.87 ± 0.81 mm. This was an
improvement over 4.75 ± 2.62 mm before registration. When the registrations were
performed every second during the biopsy, the RMS TRE was reduced to 1.63 ± 0.51
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mm. However, for a 3D data set acquired under a more controlled range of probe
pressures intended to test the robustness of the algorithm, the RMS TRE was found to be
3.18 ± 1.6 mm. This was an improvement from 6.89 ± 4.1 mm before registration.
Assuming this TRE and the TRE resulting from tissue displacement during needle
insertion (Chapter 2) are independent, they can be added in quadrature to determine an
overall TRE that can be compared against the 2.5 mm TRE threshold in the central
hypothesis. From Chapter 2, we measured an RMS TRE of 1.1 mm; adding (in
quadrature) a further TRE of 2.3 mm to this 1.1 mm yields a total of 2.5 mm. Thus, for
the central hypothesis of this work to be confirmed, an image registration algorithm with
RMS TRE ≤ 2.3 mm is required. While the results in this chapter showed encouraging
results in improving the accuracy in needle targeting, the measured 3.18 mm RMS TRE
suggests that further improvements in accuracy and robustness could be helpful to meet
the clinical requirements for successful translation of this method.

1.10.3 Chapter 4 – Evaluating the utility of intra-procedural 3D TRUS
image information in guiding registration for displacement compensation
during prostate biopsy.
The 2D-3D registration for motion compensation described in Chapter 3 can be
challenging in cases where a single plane 2D TRUS plane does not capture enough
anatomical context to drive the registration algorithm to the desired solution. While 2D
TRUS images are widely used for intra-procedural guidance, some solutions utilize richer
intra-procedural images such as bi- or multi-planar TRUS or 3D TRUS, acquired by
specialized probes. In this chapter, the impact of such richer intra-procedural imaging on
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motion compensation accuracy was measured to evaluate the tradeoff between cost and
complexity of intra-procedural imaging versus improved motion compensation. Baseline
and intra-procedural 3D TRUS images were acquired from 29 patients at standard
sextant-template biopsy locations. Planes extracted from 3D TRUS images acquired at
sextant positions were used to simulate 2D and 3D intra-procedural information available
in different potential clinically-relevant scenarios for co-registration with the baseline 3D
TRUS image. In practice, intra-procedural 3D information can be acquired either via the
use of specialized ultrasound probes (e.g., multi-planar or 3D probes) or via axial rotation
of a tracked 2D TRUS probe. Registration accuracy was evaluated by calculating the
TRE using manually-identified homologous intrinsic fiducial markers (microcalcifications). The TRE was analysed separately at the base, mid-gland and apex regions
of the prostate.
The results indicated that TRE improved gradually as the number of intraprocedural imaging planes used in registration was increased, implying that 3D TRUS
information assisted the registration algorithm to robustly converge to more accurate
solutions. The acquisition of a partial volume up to the angle of rotation supported more
accurate motion compensation than acquiring bi-plane configurations. Additional intraprocedural 3D TRUS image information was more beneficial to registration accuracy in
the base and apex regions as compared with the mid-gland region
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1.10.4 Chapter 5 – Robust 2D-3D registration optimization to motion
compensation using learned prostate motion data
In the previous chapter, we investigated a mechanism to achieve robust registration for
motion compensation during biopsy by acquiring additional intra-procedure image
information. In this chapter, we discuss an alternative approach to registration to
improve accuracy and robustness. We developed and evaluated a registration algorithm
in which the optimization is based on learned prostate motion characteristics of the
prostate. We performed an unsupervised clustering of rigid prostate motion vectors
observed in our data set. We developed a multi-start search strategy, starting at each
cluster mean and then directing the search towards the areas where motion vectors had
already been observed by appropriately scaling the search space and specifying the initial
search directions during optimization using the Powell’s direction set method.
Prostate motion analysis and registration validation was performed using a leaveone-out-cross-validation approach using the 3D TRUS images acquired from 29 patients
at baseline and sextant template biopsy locations. With this method the RMS TRE ± std
improved from 4.9 ± 2.35 mm to 2.3 ± 1.1 mm. The initial approach described in Chapter
3 yielded an accuracy of 3.1 ± 1.7 mm with this data set. Compared to the initial
approach, the updated optimization method improved the robustness during 2D-3D
registration by reducing the number of registrations with a TRE > 5 mm from 9.2% to
1.2%. With a total execution time of 2.8 s to perform motion compensation, this method
is amenable to useful integration into a clinical 3D guided prostate biopsy workflow.
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Chapter 2.
Quantification of prostate deformation due to needle
insertion during TRUS-guided biopsy: Comparison of
hand-held and mechanically stabilized systems
2.1 Introduction
Prostate biopsy is currently the clinical standard for definitive diagnosis, and twodimensional (2D) transrectal ultrasound (TRUS) is the most common imaging modality
used for guidance during biopsy. However, TRUS-guided biopsy suffers from significant
limitations related to difficulties in targeting predefined locations within the prostate,
resulting in a false negative rate as high as 29.1% [1]. The limited anatomic information
provided by 2D TRUS makes navigation to predefined 3D locations challenging [2], and
does not permit a 3D record of biopsy locations, which can be useful in a repeat session
wherein previously-determined suspicious targets may need to be rebiopsied. In order to
overcome these drawbacks, magnetic resonance imaging (MRI) and TRUS guided
systems have been developed to provide biopsy location information in 3D [3-5]. In
these systems, biopsy target locations can be determined from previous biopsy sessions,
or the radiologist's assessment of an image from a different modality.
In order to be translated to clinical use, a biopsy system should meet the criterion
of sampling tumours greater than or equal to a clinically significant minimum size with
95% confidence. A minimum significant prostate cancer volume of 0.5 cm3 (5 mm
radius under an assumption of spherical tumour shape) has been previously established
[6]. To meet the targeting criterion, the root-mean-square (RMS) error of a biopsy
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system's delivery of needles to targets must be less than 2.5 mm [7]. There are several
potential sources of error in biopsy systems: (1) mechanical guidance system errors, (2)
imaging and calibration errors, (3) patient and prostate motion due to discomfort during
the procedure, (4) prostate deformation due to biopsy needle insertion prior to firing the
biopsy gun, and (5) prostate deformation due to biopsy gun firing. The effects of the first
three sources of error have been quantified previously [3, 5, 7]. The cumulative effect of
all of the above sources has been quantified in the context of MRI-guided biopsy [8]. We
hypothesize that deformations due to needle insertion and biopsy gun firing are different
in the context of TRUS-guided biopsy due to several important differences in physical
configuration. In contrast to the robotic procedure described in Xu et al. [8], where an
endorectal coil in a cylindrical housing is placed parallel to the rectal wall for imaging,
TRUS-guided biopsy is typically conducted using an end-firing ultrasound transducer,
where the spherical transducer tip is manipulated against the anterior rectal wall in order
to obtain images. The MR-guided robot in Xu et al. [8] inserts needles into the prostate
through the rectal wall at an oblique angle to the endorectal coil housing, whereas in endfiring TRUS biopsy, the needles are nearly parallel to the probe axis. It is reasonable to
expect that these differences in physical configuration may lead to differing mechanical
dynamics at the time of biopsy needle insertion and gun firing, resulting in different
prostate deformation characteristics. The effect of needle insertion on prostate motion
has been studied extensively in the context of brachytherapy procedures [9, 10], where
the patient is under general anesthesia and the brachytherapy needles are inserted slowly
(relative to the rapid firing speed of a biopsy gun) through the perineum. It is reasonable
to consider that the effect of the needle in the context of biopsy may be different due to
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the reactions (e.g., in the form of pelvic floor muscle contractions) of an awake,
uncomfortable patient and the high speed of needle insertion by the biopsy gun.
The objective of this work was to quantify the deformation caused by the needle
insertion and biopsy gun firing procedure. The three main contributions of the present
work are: (1) to compute clinically relevant confidence intervals around the tissue
deformation, accounting for the measured error in our approach to measuring this
deformation; (2) to compare the amount of lateral deformation, in the direction
orthogonal to the needle, to the amount of axial deformation, in the direction parallel to
the needle; and (3) to compare the deformation resulting from the traditional approach to
2D TRUS-guided biopsy where the probe is hand held with that resulting from the use of
mechanically assisted biopsy system [5]. With respect to contribution (1), we computed
a spatially varying confidence interval around the amount of tissue deformation induced
during these two actions in order to permit the determination the difference between the
location sampled by the biopsy needle and the planned target location. This is a useful
measure from a clinical standpoint, since this confidence interval can be used to
determine the smallest tumour that can be accurately sampled with 95% confidence,
under the assumption of zero error in all other aspects of the biopsy system. Our initial
work on this problem, addressed this quantification in terms of a spatially varying mean
and standard deviation of the deformation magnitudes [11]. With respect to contribution
(2), given the long, narrow (19 mm × 0.8 mm) cylindrical shape of the biopsy core, it is
useful to decompose the tissue motion into its axial and lateral components, since axial
motion poses less of a problem for targeting, compared to lateral motion. With respect to
contribution (3), we hypothesize that the characteristics of prostate deformation may
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differ when using a hand held TRUS probe during needle insertion and gun firing, as
compared with using our mechanically stabilized system where the interaction between
the physician and the system is more controlled.

2.2 Materials and Methods
2.2.1 Data Acquisition
We acquired images using a conventional hand held 2D-TRUS biopsy system and a
mechanically assisted 3D TRUS biopsy guidance system developed in our laboratory [5]
as part of a larger human subjects research ethics board approved MRI-3D TRUS fusion
biopsy study of our institution. This system consists of passive mechanical components
for guiding, tracking and stabilizing the position and orientation of a conventional TRUS
probe (Figure 2.1). The stabilization is accomplished using a mechanical spring-loaded
counter-balancing system that maintains the position and orientation of the probe even
when the physician removes his hand from the handle. This permits smooth motion of
the transducer with a light touch of the physician's hand. In addition, the configuration of
the device is such that there exists a remote center of motion (RCM) at a point near to the
tip of the TRUS probe. The RCM is intended to minimize prostate motion during
reorientation of the probe to aim for different targets in the biopsy plan.
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Spring loaded
counterbalance

Biopsy gun clip

Needle guide

Figure 2.1: Mechanically assisted 3D TRUS-guided biopsy system. The biopsy gun is retained in a clip
and the needle is coupled to the TRUS probe using a needle guide. A spring-based counter balancing
system maintains probe position and orientation even when the physician removes his hand from the probe.

For both the hand held and mechanically assisted approaches, we used a
Philips/ATL HDI 5000 ultrasound machine with a 5-9 MHz end-firing TRUS transducer
probe (model C9-5, Philips, Bothell, WA, USA) to acquire images, and a Magnum
biopsy gun (C. R. Bard, AZ, USA) to take biopsy samples. We utilized a video capture
board to acquire and digitize video from the ultrasound machine's composite video output
at a minimum of 10 Hz, recording the 2D ultrasound images (with isotropic pixels of size
0.19 mm) obtained during the entire biopsy procedure for each patient. Across 16
patients, 𝑁𝑠 = 190 biopsies were obtained (i.e., an average of 12 biopsies per patient). 96
biopsies were taken from 9 patients using the hand held system, and 94 biopsies were
taken from 7 patients using the mechanically assisted system. For each biopsy, we
manually selected 3 video frames, denoting each frame triplet as a biopsy sequence, each
of which is assigned a number 𝑠 between 1 and 𝑁𝑠 . The sequence consists of (1) the
image 𝐼𝑠1 acquired immediately prior to needle insertion, (2) the image 𝐼𝑠2 acquired
50

immediately prior to biopsy gun firing, and (3) the image 𝐼𝑠3 acquired immediately after
biopsy gun firing (Figure 2.2). Formally, 𝐼𝑠𝑖 : Ω → ℝ, where 𝑖 ∈ {1,2,3}, 𝑠 ∈ {1 … 𝑁𝑠 },
and Ω ⊂ ℝ2 represents the domain of the image.
Registration 3

Registration 1

Registration 2

Before needle insertion

After biopsy gun firing
After needle insertion

Figure 2.2: Images in a biopsy sequence, and the names used for the three indicated registrations
throughout this paper. The first image occurs immediately prior to the physician's insertion of the biopsy
needle. The second image occurs immediately prior to firing the biopsy gun, and the third image occurs
immediately after the biopsy gun has been fired. The dotted curves indicate portions of the prostate
boundary that interact with the needle, which lies between the two solid vertical segments in the second and
third images; note the deformation at the lower piercing point.

2.2.2 Image registration
Our method is described at a high level in the block diagram given in Figure 2.3. The
process begins with the registration of an image pair, where one image is designated as
the fixed image, and the other is designated as the moving image. For each biopsy
sequence, we performed three such registrations, described in Figure 2.3. Throughout the
remainder of this paper, for a biopsy sequence 𝑠, registration 1 refers to the registration of
𝐼𝑠1 to 𝐼𝑠3 and reports the combined deformation resulting from both the needle insertion
and the biopsy gun firing procedures. Registration 2 refers to the registration of 𝐼𝑠1 to 𝐼𝑠2
and reports the deformation resulting from needle insertion only. Registration 3 refers to
the registration of 𝐼𝑠2 to 𝐼𝑠3 and reports the deformation resulting from biopsy gun firing
only. For each indicated image pair, we designated the image at the earlier time point as
the moving image and the image at the later time point as the fixed image, since these
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designations reflect the movement of the tissue through time during the procedure. We
normalized the images with respect to the position of the biopsy needle by flipping the
images (if necessary) so that the needle lies to the left of the probe; this normalization
allows for the straightforward quantification of deformation with respect to measured
spatial distances to the needle. We then non-rigidly registered the moving image to the
fixed image, yielding a deformation vector field that we used to quantify the tissue
deformation captured by the registration. The deformation field resulting from
registration 𝑟 of biopsy sequence 𝑠 is denoted 𝑉𝑠𝑟 : Ω → ℝ2 and gives the magnitude and
direction of deformation at each location in the image domain. We refer to the lateral (𝑥)
𝑦

and axial (𝑦) components of the deformation field as 𝑉𝑠𝑟𝑥 : Ω → ℝ and 𝑉𝑠𝑟 : Ω → ℝ,
𝑦

respectively; Figure 2.4 provides an illustration of the magnitudes of 𝑉𝑠𝑟 , 𝑉𝑠𝑟𝑥 , and 𝑉𝑠𝑟 for
one sequence. We tested the following three registration algorithms, with the specified
tuning parameters: (1) Demons [12] (standard deviation of smoothing kernel: 1 mm,
number of histogram levels: 1024, number of match points: 7), symmetric forces Demons
[13] (using the same parameters as for the Demons algorithm) and B-spline [14] (Bspline order: 3, grid spacing: 0.72 mm, similarity metric: normalized cross correlation).
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TRE calculation

Fiducial points

Moving image

Non rigid
registration

Deformation field

Deformation
measurements

Fixed image
Prostate boundary
& needle location

Figure 2.3: Overall process used in this work. The moving image (from an earlier time point) is registered
to the fixed image (from a later time point) using non-rigid registration. This yields a deformation vector
field that is used to quantify the underlying motion of the tissue. The error in the non-rigid registration
algorithm is measured by calculating a TRE based on corresponding intrinsic fiducial markers.
Measurements, incorporating the TRE, are then taken from the deformation vector field to characterize the
underlying motion of the prostate tissue in response to the insertion of the biopsy needle and firing of the
biopsy gun.
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Figure 2.4: (a) Deformation vector field magnitude with prostate boundary and needle location indicated.
(b) Lateral (x) components of the deformation field. (c) Axial (y) components of the deformation field. The
needle axis lies between the vertical white line is each image.

2.2.3 Image registration validation
The accuracy of a deformation vector field in describing the motion of the tissue depicted
in the registered images is influenced by the error of the registration algorithm that
generated the deformation vector field.

We evaluated each image registration algorithm

by estimating its TRE using manually marked, anatomically homologous intrinsic
fiducial markers (naturally occurring calcifications) visible in a subset of the images to be
registered (Figure 2.5). The TRE is calculated as the RMS error of the spatial locations
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of corresponding fiducials, post-registration [15]. To compute the TRE for each
algorithm, we performed registrations 1, 2, and 3 on 21 biopsy sequences taken from 4
patients. A total of 390 fiducials were identified and localized in the tested images. To
determine the location of each fiducial, an operator localized the fiducial five times
during separate sessions, and the centroid (arithmetic mean) of the operator's five selected
locations was taken as the estimate of the location of the fiducial. These repeated
localizations were also used to compute the fiducial localization error (FLE) as 𝐹𝐿𝐸 =
1

√ ∑𝑘 𝐹𝐿𝐸𝑘2 , where 𝐹𝐿𝐸𝑘2 = 𝜎 2 (𝑥𝑘 ) + 𝜎 2 (𝑦𝑘 ), and 𝜎 2 (𝑥𝑘 ) and 𝜎 2 (𝑦𝑘 ) are the
𝑁
variances of the 𝑥- and 𝑦-coordinates, respectively, of the repeated localizations of the 𝑘th
fiducial.

Figure 2.5: Calcifications used to validate the registration algorithms, indicated by arrows.

2.2.4 Quantification of deformation
A clinical objective of image-guided prostate biopsy is to obtain tissue samples from
regions of the prostate defined as biopsy targets. In conventional 2D TRUS-guided
54

biopsy, these targets may be determined according to a predefined pattern (e.g., as in
sextant biopsy), or may be determined at time of biopsy based on a visual assessment of
the ultrasound image by the physician. In 3D TRUS-guided systems [3, 5], targets may
be determined via the physician's assessment of an image of a different modality (e.g.,
MRI) or based on biopsy targets in a previous 3D TRUS-guided biopsy session [7].
Regardless of the means of defining the target, the physician will insert the biopsy needle
through the rectal wall with a trajectory intersecting with the target, advancing the needle
tip sufficiently such that the target lies within the throw of the biopsy gun, and then
activate the trigger to fire the gun and obtain a sample. It is therefore of interest to
quantify the deformation of the prostate tissue proximal to the trajectory of the needle
throughout this procedure, in order to determine how far the target may move from the
needle path. There are two key aspects to this quantification: (1) defining the appropriate
statistical descriptions of the deformation field to characterize the underlying tissue
motion within a confidence interval, and (2) defining relevant spatial regions within
which these statistics are to be calculated. We define the statistics in Section 2.2.4.1 and
the spatial regions in Section 2.2.4.2. In Section 2.2.4.2, we describe the specific
measurements computed in this paper using the defined statistics and regions.
2.2.4.1 Deformation vector field statistics
We calculated three statistics: (1) a signed mean of the deformation vector field, to
measure coherent tissue motion in some direction; (2) a standard deviation of the vector
field, to obtain a confidence interval around the amount of deformation observed in the
tissue; and (3) a standard deviation of the vector field that incorporates the measurement
error given by the TRE.
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Statistic 1: Signed mean of the deformation field. This statistic was computed
by summing each of the two signed components of the deformation vectors
independently, and squaring and adding the results to obtain a measure of coherence in
the motion depicted by the deformation vector field. The signed mean distance across all
sequences for a particular registration 𝑟 (1, 2 or 3) is defined as
1
|𝑃𝑠 |
𝑠
̅𝑟 (𝑃) = ‖ 1 ∑𝑁
𝐷
𝑠=1 (|𝑃 |) ∑𝑖=1 𝑉𝑠𝑟 (𝒑𝑖 ∈ 𝑃𝑠 )‖,
𝑁
𝑠

(2.1)

𝑠

where 𝑃 = {𝑃1 , 𝑃2 , … , 𝑃𝑁𝑠 } is a set of point sets, one per sequence, and |𝑃𝑠 | is taken to be
the cardinality of set 𝑃𝑠 . The parameter 𝑃 allows for the specification of the region of the
deformation vector field over which the statistic is to be computed. The elements of
𝑃 allow for the definition of a different region for each sequence.
Statistic 2: Standard deviation of the deformation field. The standard deviation
of the distribution of deformation vectors for all sequences for a registration 𝑟 is
̂𝑟 (𝑃)2 − 𝐷
̅𝑟 (𝑃)2,
𝜎̃𝑟 (𝑃) = √𝐷

(2.2)

where the RMS of the deformation is defined as
̂𝑟 (𝑃) =
𝐷

1
𝑁𝑠

1
|𝑃 |
∑ 𝑠 ‖𝑉 (𝒑𝑖
|𝑃𝑠 | 𝑖=1 𝑠𝑟

𝑠
∑𝑁
𝑠=1 (

∈ 𝑃𝑠 )‖).

(2.3)

The standard deviation 𝜎̃𝑟 (𝑃) is a useful statistic in that it permits the calculation
of a confidence interval around the amount of tissue motion in a region of interest defined
by 𝑃. However, 𝜎̃𝑟 (𝑃) represents the variability of the deformation of the prostate tissue
under the assumption of zero measurement error, i.e., zero TRE. Our motivation for
performing this calculation is to compare it with the analogous calculation (defined in the
next paragraph) that incorporates the TRE, in order to assess the impact of the
registration error on the computed confidence interval on the estimated tissue motion.
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Statistic 3: Standard deviation of the deformation field, incorporating the
TRE. In a given registration of a moving image to a fixed image, every point in the
moving image has an anatomically homologous point in the fixed image to which it
would be transformed by an ideal registration algorithm. In practice, a given registration
algorithm transforms each point in the moving image to a point which is some (possibly
nonzero) distance away from its anatomically homologous point in the fixed image. If
we define the anatomically homologous point given by the ideal registration algorithm as
our “true target”, the error of a non-ideal registration algorithm places the transformed
points from the moving image around the true target according to some distribution.
Under the assumption that this distribution is normal, the TRE gives an estimate of its
standard deviation. Deformation vector fields generated by a registration algorithm with
a nonzero TRE therefore give an approximate measure of the deformation of the tissue,
which is reflected in a larger confidence interval on the estimated tissue deformation due
to needle insertion and biopsy gun firing. The TRE, measured as an RMS error, adds
uncertainty regarding the tissue motion to the uncertainty described by the measured
standard deviation of the deformation vector field. These uncertainties are combined by
taking their quadratic sum [16] as
𝜎𝑟 (𝑃) = √𝜎̃𝑟 (𝑃)2 + 𝑇𝑅𝐸 2 ,

(2.4)

The 95% confidence interval on the magnitude of the prostate tissue displacement
is given by 1.96𝜎𝑟 (𝑃). To measure the tissue deformation along the lateral (𝑥) and axial
(𝑦) directions separately, we computed
𝜎𝑟𝑥 (𝑃) = √𝜎̃𝑟𝑥 (𝑃)2 + (𝑇𝑅𝐸 𝑥 )2 and
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(2.5)

𝑦

𝑦

𝜎𝑟 (𝑃) = √𝜎̃𝑟 (𝑃)2 + (𝑇𝑅𝐸 𝑦 )2,

(2.6)

respectively, where 𝑇𝑅𝐸 𝑥 and 𝑇𝑅𝐸 𝑦 are the dimensional components of the TRE, and
̂𝑟𝑥 (𝑃)2 − 𝐷
̅𝑟𝑥 (𝑃)2,
𝜎̃𝑟𝑥 (𝑃) = √𝐷
1
|𝑃𝑠 | 𝑥
𝑠
̅𝑟𝑥 (𝑃) = ‖ 1 ∑𝑁
𝐷
𝑠=1 (|𝑃 |) ∑𝑖=1 𝑉𝑠𝑟 (𝒑𝑖 ∈ 𝑃𝑠 )‖,
𝑁
𝑠

̂𝑟𝑥 (𝑃) =
𝐷

1
𝑁𝑠

𝑠

1
|𝑃 |
∑ 𝑠 ‖𝑉 𝑥 (𝒑𝑖
|𝑃𝑠 | 𝑖=1 𝑠𝑟

𝑠
∑𝑁
𝑠=1 (

∈ 𝑃𝑠 )‖).

(and similarly for the 𝑦 dimension).
2.2.4.2 Measured regions
We calculated the statistics of deformation vector fields lying within three different types
of image regions: (1) regions at a specific signed distance to the needle axis, (2) regions
within an unsigned distance of the needle axis, and (3) regions at a specific unsigned
distance to the point where the biopsy needle enters the prostate (henceforth referred to as
the lower piercing point).
Region 1: Deformation vectors at a signed distance to the needle axis. The set
of points in the image domain lying at a distance 𝑑 from the needle axis 𝐴 for sequence 𝑠
is defined as
𝐴
𝑃𝑠𝑑
= {𝒑𝑖 ∈ Ω | 𝐷𝐴 (𝐴𝑠 , 𝒑𝑖 ) = 𝑑},

(2.7)

where
𝐴𝑠 = {𝒍𝑠 + 𝑡𝒂𝑠 | 𝑡 ∈ ℝ},
defines the needle axis for sequence 𝑠, with 𝒍𝑠 defining the lower piercing point and 𝒂𝑠
defining the needle axis direction. 𝐷𝐴 (𝐴𝑠 , 𝒑𝑖 ) gives the signed perpendicular distance
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between 𝒑𝑖 and the needle axis, with negative distance values defined for points lying to
𝐴
𝐴
the left of the needle axis. 𝑃𝑑𝐴 = {𝑃1𝑑
, 𝑃1𝑑
, … , 𝑃𝑁𝐴𝑠 𝑑 } the set of such regions at distance 𝑑

for all sequences.
Region 2: Deformation vectors within an unsigned distance of the needle axis.
The set of points from sequence 𝑠 in the image domain lying within a region of the
needle axis (“axis region” denoted as 𝐴𝑅) defined by a distance 𝑑 is defined as
𝐴𝑅
𝑃𝑠𝑑
= {𝒑𝑖 ∈ Ω | 𝐷𝐴 (𝐴𝑠 , 𝒑𝑖 ) ≤ 𝑑}.

(2.8)

𝐴𝑅
𝐴𝑅
𝑃𝑑𝐴𝑅 = {𝑃1𝑑
, 𝑃1𝑑
, … , 𝑃𝑁𝐴𝑅
}, the set of such regions at distance 𝑑 for all sequences.
𝑠𝑑

Region 3: Deformation vectors at a specific unsigned distance to the lower
piercing point. The set of points in the image domain lying at a distance d from the
lower (denoted as “𝑙”) piercing point for sequence 𝑠 is defined as
𝑙
𝑃𝑠𝑑
= {𝒑𝑖 ∈ Ω | 𝐷𝑙 (𝒍𝑠 , 𝒑𝑖 ) = 𝑑},

(2.9)

where 𝐷𝑙 (𝒍𝑠 , 𝒑𝑖 ) gives the unsigned Euclidean distance between 𝒑𝑖 and the lower
𝑙
𝑙
piercing point. 𝑃𝑑𝑙 = {𝑃1𝑑
, 𝑃1𝑑
, … , 𝑃𝑁𝑙 𝑠 𝑑 }, the set of such regions at distance 𝑑 for all

sequences.
2.2.4.3 Prostate tissue deformation measurements
Using the statistics and regions defined above, we computed four different measures of
prostate tissue deformation, defined in the paragraphs below.
Measurement 1: Deformation as a function of distance to the needle axis. The
̅𝑟 (𝑃𝑑𝐴 ), the standard deviation, 𝜎̃𝑟 (𝑃𝑑𝐴 ), and the standard deviation
signed mean, 𝐷
incorporating the TRE, 𝜎𝑟 (𝑃𝑑𝐴 ), were determined for regions 𝑃𝑑𝐴 at specific signed
distances 𝑑 to the needle axis (Figure 2.6). These measurements were performed
59

separately for 𝑟 = 1,2,3, with 𝑑 = [-15 mm, 50 mm], a sufficiently large domain to cover
all of the prostates in our study. The purpose of these measurements was to find the 95%
confidence interval (1.96𝜎𝑟 (𝑃𝑑𝐴 )) on the estimated prostate tissue motion, as well any
̅𝑟 (𝑃𝑑𝐴 )), as a function of distance to the needle
directionally coherent tissue motion (𝐷
axis. Since the biopsy target is presumably near to the needle axis, these measurements
allow for the interrogation of a region of clinical interest to determine the amount by
which the tissue may move away from the needle during biopsy. Comparing the 95%
confidence interval on the tissue motion that incorporates the measured TRE with the
corresponding confidence interval computed under the assumption of zero TRE permits
the assessment of the effect of the registration error on the confidence interval estimate.

Needle Axis
As

DA

.P

D
Is
Figure 2.6: Diagram depicting a prostate contoured on a 2D TRUS image with the needle axis 𝐴𝑠 to the
left of the probe, as in all of our images. The perpendicular distance 𝐷𝐴 of a point 𝑃 to the needle axis is
shown. The lower piercing point 𝑙𝑠 is indicated, as is the distance 𝐷𝑙 between 𝑃 and the lower piercing
point.

Measurement 2: Deformation as a function of distance to the lower piercing
̅𝑟 (𝑃𝑑𝑙 ), the standard deviation, 𝜎̃𝑟 (𝑃𝑑𝑙 ), and the standard
point. The signed mean, 𝐷
deviation incorporating the TRE, 𝜎𝑟 (𝑃𝑑𝑙 ), were determined for regions 𝑃𝑑𝑙 at specific
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unsigned distances 𝑑 to the lower piercing point (Figure 2.6). These measurements were
performed separately for 𝑟 = 1, 2, 3, with 𝑑 = [0 mm, 30 mm], a sufficiently large domain
to cover all of the prostates in our study. The purpose of these measurements was to find
the 95% confidence interval (1.96𝜎𝑟 (𝑃𝑑𝑙 )) on the estimated prostate tissue motion, as well
̅𝑟 (𝑃𝑑𝑙 )), as a function of distance to the lower
any directionally coherent tissue motion (𝐷
piercing point. These measurements allow for the comparison of the amounts by which
the tissue may move away from the biopsy needle when the target is proximal to the
piercing point (e.g., target A in Figure 2.7), and when the target is far from the piercing
point (e.g., target B in Figure 2.7). This is particularly important since up to 80% of
prostate cancer is found in the peripheral zone [17, 18], which lies near to the posterior
side where the biopsy needle enters the prostate after penetrating the rectal wall (Figure
2.7).

AZ

Anterior

TZ
Urethra
Inferior

Superior

CZ
C

B

PZ
A
Biopsy
Posterior
needle
trajectories

Figure 2.7: Diagram depicting prostate anatomy in a sagittal view, indicating the peripheral zone (PZ),
central zone (CZ), transition zone (TZ), and anterior zone (AZ). Three biopsy targets are shown as A, B,
and C. The biopsy needle enters the prostate on the posterior side by penetrating the rectal wall, as shown.

Measurement 3: Deformation in the lateral and axial directions. The standard
deviations incorporating the TRE along the lateral (𝑥) and axial (𝑦) directions for
𝑦

registration 1, computed as 𝜎1𝑥 (𝑃𝑑𝐴 ) (Equation 2.5) and 𝜎1 (𝑃𝑑𝐴 ) (Equation 2.6),
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respectively, were determined for regions 𝑃𝑑𝐴 at specific signed distances 𝑑 to the needle
𝑦

axis (Equation 2.7). 𝜎1𝑥 (𝑃𝑑𝑙 ) and 𝜎1 (𝑃𝑑𝑙 ) are also calculated for regions 𝑃𝑑𝑙 at specific
unsigned distances 𝑑 to the lower piercing point (Equation 2.9). These give
decompositions of the two quantifications described above into the lateral and axial
directions. The observation of these decompositions is useful because of the highly
anisotropic (long, narrow) nature of the biopsy core; axial tissue motion parallel to the
needle poses less of a problem with respect to targeting than does lateral tissue motion.
Measurement 4: Deformation as a function of lateral position of the needle
relative to the prostate. The standard deviation incorporating the TRE, computed as
𝐴𝑅
𝜎1 (𝑃5𝐴𝑅
𝑚𝑚 ), was determined for the region 𝑃5 𝑚𝑚 within 5 mm of the needle axis

(Equation 2.8). This was calculated for registration 1 as a function of 𝑤, the lateral
position of the needle normalized with respect to the width of the prostate as seen on the
2D TRUS image. At the boundary of the prostate on the 2D TRUS image on the left side
of the needle, 𝑤 = 0, in the middle of the prostate, 𝑤 = 0.5, and at the boundary of the
prostate on the right side of the needle, 𝑤 = 1. The purpose of this measurement is to
investigate the relationship (if any) between the distance of the target from the edge of
the prostate, and the amount of tissue deformation that occurs within a clinically
meaningful distance of the needle axis. This is illustrated by Figure 2.7; this measurement
permits the determination of the difference in deformation when aiming the needle for
target A (closer to the middle of the prostate), compared to target C (closer to the edge of
the prostate).
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2.3 Results
2.3.1 Image registration validation
Table 1 shows the measured TRE values before and after registration for each of the
tested algorithms. The symmetric forces Demons registration algorithm was selected for
use in this study since it provided the best overall improvement in the TRE. This
algorithm is based on optical flow techniques, which have been shown to be suitable for
tracking fine-scale structure in ultrasound images in the presence of small tissue
deformation [19]; this class of algorithms is therefore suitable for our problem. The
calculated FLE was 0.11 mm.
Table 2.1: Comparison of TRE before and after registration for each tested registration method.
Registration 1 captures tissue motion during needle insertion and biopsy gun firing, registration 2 captures
needle insertion only, and registration 3 captures biopsy gun firing only.
Registration method
Before registration
Demons [12]
Symmetric Forces Demons [13]
B-spline [14]

Registration 1 TRE
(mm)
0.51
0.24
0.23
0.46

Registration 2
TRE (mm)
0.31
0.13
0.14
0.28

Registration 3
TRE (mm)
0.40
0.23
0.22
0.37

2.3.2 Quantification of deformation
Measurement 1: Deformation as a function of distance to the needle axis. Figure 2.8
̅𝑟 (𝑃𝑑𝐴 ), the 95% confidence interval, 1.96𝜎̃𝑟 (𝑃𝑑𝐴 ), and the
plots the mean deformation, 𝐷
95% confidence interval incorporating the TRE, 1.96𝜎𝑟 (𝑃𝑑𝐴 ), versus the signed distance
𝑑 to the needle axis. It can be observed that the coherent tissue motion is relatively small
compared to the total amount of deformation (comparing the lowermost curve to the
uppermost curve), and that the TRE makes a relatively small contribution to the width of
the 95% confidence interval (comparing the middle curve to the uppermost curve). A
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local increase in deformation proximal to the needle axis is observed for both systems,
with biopsy gun firing being the main contributor to this deformation for the hand held
system, and the only contributor for the mechanically assisted system. A two-tailed t-test
showed that 1.96𝜎𝑟 (𝑃𝑑𝐴 ) was statistically significantly different when comparing the hand
held system to the mechanically assisted system (p < 0.05), for |𝑑| < 20 mm.
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Figure 2.8: Deformation versus distance to the needle axis. Dashed curve: the signed mean of the
̅𝑟 (𝑃𝑑𝐴 )). Dotted curve: the 95% confidence interval around the tissue deformation (𝜎̃𝑟 (𝑃𝑑𝐴 )).
deformation (𝐷
Solid curve: the 95% confidence interval incorporating the TRE (𝜎𝑟 (𝑃𝑑𝐴 )). (a, b): registration 1, (c, d):
registration 2, (e, f): registration 3. (a, c, e): hand held, (b, d, f): mechanically assisted.
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Figure 2.9: Deformation versus distance to the lower piercing point. Dashed curve: the signed mean of the
̅𝑟 (𝑃𝑑𝑙 )). Dotted curve: the 95% confidence interval around the tissue deformation (𝜎̃𝑟 (𝑃𝑑𝑙 )).
deformation (𝐷
Solid curve: the 95% confidence interval incorporating the TRE (𝜎𝑟 (𝑃𝑑𝑙 )). (a, b): registration 1, (c, d):
registration 2, (e, f): registration 3. (a, c, e): hand held, (b, d, f): mechanically assisted.

66

Measurement 2: Deformation as a function of distance to the lower piercing
̅𝑟 (𝑃𝑑𝑙 ), the 95% confidence interval,
point. Figure 2.9 plots the mean deformation, 𝐷
1.96𝜎̃𝑟 (𝑃𝑑𝑙 ), and the 95% confidence interval incorporating the TRE, 1.96𝜎𝑟 (𝑃𝑑𝑙 ), versus
the signed distance 𝑑 to the needle axis. As in Figure 2.8, it can be observed that the
coherent tissue motion is small relative to the total amount of deformation and that the
TRE is not a substantially contributing factor. It can also be observed that in general,
more deformation occurs proximal to the lower piercing point. A two-tailed t-test showed
that 1.96𝜎𝑟 (𝑃𝑑𝑙 ) was statistically significantly different when comparing the hand held
system to the mechanically assisted system (p < 0.05), for 𝑑 ≥ 1 mm.
Measurement 3: Deformation in the lateral and axial directions. Figure
2.10(a-b) plot the 95% confidence interval on the tissue deformation, 1.96𝜎1 (𝑃𝑑𝐴 ), versus
distance to the needle axis, and its lateral and axial components, 1.96𝜎1𝑥 (𝑃𝑑𝐴 ) and
𝑦

1.96𝜎1 (𝑃𝑑𝐴 ), respectively. Figure 2.10(c-d) plot the 95% confidence interval on the tissue
deformation, 1.96𝜎1 (𝑃𝑑𝑙 ), versus distance to the lower piercing point, and its lateral and
𝑦

axial components, 1.96𝜎1𝑥 (𝑃𝑑𝑙 ) and 1.96𝜎1 (𝑃𝑑𝑙 ), respectively. It can be observed that the
deformation is predominantly in the lateral (𝑥) direction proximal to the needle axis (a-b).
Proximal to the lower piercing point (c-d), the situation is the opposite, with dependence
predominantly in the axial (𝑦) direction.
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Hand held

Mechanically assisted

(a)

(b)

(c)

(d)

Reg. 1

Reg. 2

Figure 2.10: Lateral-axial decompositions of the 95% confidence intervals shown in Figures 8 and 9, for
registration 1. (a, b): Deformation versus distance to the needle axis. Solid curve: the 95% confidence
interval around the tissue deformation incorporating the TRE (𝜎𝑟 (𝑃𝑑𝐴 )). Dashed curve: the lateral (𝑥)
𝑦
component of this confidence interval (𝜎𝑥1 (𝑃𝐴𝑑 )) Dotted curve: the axial (𝑦) component (𝜎1 (𝑃𝐴𝑑 )). (c, d):
Deformation versus distance to the lower piercing point. Solid curve: the 95% confidence interval around
the tissue deformation incorporating the TRE (𝜎𝑟 (𝑃𝑑𝑙 )). Dashed curve: the lateral (𝑥) component of this
confidence interval (𝜎𝑥1 (𝑃𝑙𝑑 )). Dotted curve: the axial (𝑦) component (𝜎𝑥1 (𝑃𝑙𝑑 )) (a, c): hand held, (b, d):
mechanically assisted.

Measurement 4: Deformation as a function of lateral position of the needle
relative to the prostate. Figure 2.11 plots the 95% confidence interval on the tissue
deformation in the region within 5 mm of the needle axis, 1.96𝜎1 (𝑃5𝐴𝑅
𝑚𝑚 )as a function of
the position of the biopsy needle relative to the left edge of the prostate as seen on the 2D
TRUS image (0 is the left edge, 1 is the right edge, and 0.5 is the middle). Since the
68

needle is consistently oriented to the left side of the probe in our images, most of the
plotted points are at less than 0.5 on the horizontal axis. The correlation ratio was found
to be -0.17, with a 95% confidence interval of (-0.07, -0.27). The relationship is weak,
negative as shown in Figure 2.11.

Figure 2.11: Deformation as a function of lateral position of the needle relative to the prostate, for
registration 1. The distance to the left edge of the prostate is shown on the horizontal axis (0 = left edge, 0.5
= middle, 1 = right edge). The vertical axis shows the width of the 95% confidence interval on the tissue
deformation within a region lying 5 mm on either side of the needle axis (𝜎1 (𝑃5𝐴𝑅
𝑚𝑚 )). The best fit line is
plotted, showing a weak negative relationship (r = -0.17).

2.4 Discussion
2.4.1 Image registration validation
The measured TRE values before and after registration using the symmetric forces
Demons algorithm demonstrate that the registrations improve the alignment of the
fiducial markers for registrations 1, 2, and 3. Overall, for registration 1 (capturing tissue
deformation occurring during needle insertion and biopsy gun firing), 55% of the preregistration fiducial misalignment is eliminated by the algorithm. For registrations 2
(needle insertion only) and 3 (biopsy gun firing only), 55% and 45% of the preregistration fiducial misalignment is eliminated, respectively, suggesting that the
algorithm was most challenged by the registration of the images occurring before and
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after biopsy gun firing. Although the FLE accounts for less than half of the TRE for the
overall biopsy procedure (registration 1), it contributes non-trivial variability, suggesting
that the actual TRE of this algorithm may in fact be lower than our measurements
suggest. Our reported confidence intervals are therefore likely to be conservative.

2.4.2 Quantification of deformation
Measurement 1: Deformation as a function of distance to the needle axis. We
observe a maximum value of 1.96𝜎1 (𝑃𝑑𝐴 ) = 2.1 mm, occurring at 𝑑 = 0, across both
systems. Consequently, spherical tumours with radius 2.1 mm or more can be sampled
with 95% confidence, under the assumption of zero error elsewhere in the biopsy system.
Although 1.96𝜎1 (𝑃𝑑𝐴 ) has a higher plateau for the mechanically assisted system,
compared to the hand held system, the difference in deformation in the region along the
needle axis is less than 0.38 mm. This slight increase in deformation may be explained
by the fact that the mechanical system, due to its stabilization of the ultrasound probe,
does not require the physician to maintain constant inward pressure on the probe to keep
it within the rectum with good acoustic coupling to the prostate. Although this
stabilization can reduce the amount of deformation applied to the prostate as the probe is
reoriented to aim for different targets, the reduced pressure on the prostate may permit
the observed increase in tissue motion during needle insertion and biopsy gun firing. In
addition, there is less variability arising from the mechanical system in the deformation
on the lateral side of the prostate, to the left of the needle axis (compare Figure 2.8(a,e) to
Figure 2.8(b,f) for 𝑑 < 0). Feedback from our collaborating radiologist suggests that this
may be due to the mechanical system's stability in the absorption of recoil when the
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biopsy gun is fired; recall that the mechanically assisted system holds the biopsy gun in a
clip, allowing its mechanical assembly to stabilize the gun and needle during firing. In
the hand held system, the physician may be inclined to proactively compensate for recoil
by driving the biopsy gun forward slightly at the time of firing, causing the observed
lateral deformation variability. Additionally, there exists a relative increase in
deformation in the region surrounding the needle axis for the hand held system during
needle insertion (peak in the curve at 𝑑 = 0 in Figure 2.8(c)); this does not occur in the
mechanically assisted system (no peak in the curve at 𝑑 = 0 in Figure 2.8(d)). This may
be due to a slower speed of needle insertion in the mechanical system due to the fact that
biopsies taken with this system were targeted using a heads-up display, causing the
physician to take extra care when setting the initial needle trajectory during penetration of
the rectal wall.
Measurement 2: Deformation as a function of distance to the lower piercing
point. As was observed with the deformation relative to the needle axis, the deformation
relative to the lower piercing point, 1.96𝜎1 (𝑃𝑑𝑙 ), is 0.38 mm higher in the mechanically
assisted system, compared with the hand held system. Overall, the mechanically assisted
approach yields a deformation that is less dependent on the distance from the lower
piercing point, compared with the hand held approach (flatter curves in Figure 2.9(b, d,
f), compared with Figure 2.9(a, c, e)).
Measurement 3: Deformation in the lateral and axial directions. At 𝑑 = 0, the
𝑦

ratio of 𝜎1𝑥 (𝑃𝑑𝐴 ) to 𝜎1 (𝑃𝑑𝐴 ) is 1.2 for the mechanically assisted system, and 1.3 for the
hand held system. The observed lateral tissue motion proximal to the needle shaft is
expected, since tissue must be displaced laterally in order to accommodate the insertion
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of the biopsy needle into the prostate; this observation provides qualitative support for the
plausibility of the deformation vector fields generated by our chosen registration
algorithm. This analysis is motivated by the long, narrow shape of the biopsy core, so it
is of value to observe the 95% confidence interval around the lateral tissue motion along
the needle axis. This quantity is 1.3 mm for the hand held system and 1.5 mm for the
𝑦

mechanically assisted system. In both systems, the ratio of 𝜎1 (𝑃𝑑𝑙 ) to 𝜎1𝑥 (𝑃𝑑𝑙 ) is greater
than one proximal to the lower piercing point; this dependence is in the axial direction,
parallel to the needle axis, and so is of little concern given the shape of the biopsy core.
Measurement 4: Deformation as a function of lateral position of the needle
relative to the prostate. The observed weak negative relationship between
1.96𝜎1 (𝑃5𝐴𝑅
𝑚𝑚 ) and the lateral position of the biopsy needle relative to the prostate
suggests that although the tissue medial to the prostate may be more stable during biopsy,
compared with the tissue nearer to the sides, this effect is not large enough to warrant
compensation during targeting.

2.4.3 Limitations
One limitation of this work arises due to the fact that obtaining images at a suitable frame
rate to capture the deformation occurring during rapid biopsy gun firing necessitates the
use of 2D, rather than 3D, TRUS imaging. We are therefore able to quantify deformation
in directions non-parallel to the 2D TRUS imaging plane only indirectly, in several ways.
First, because the biopsy sequence images in this study were selected in part due to the
presence of visible micro-calcifications for the purposes of quantifying the TRE and FLE,
the visibility of such small structures in all three images in each sequence limits the out72

of-plane tissue motion by a function of calcification size and ultrasound beam thickness.
Second, the measured in-plane lateral dependence shown in Figure 2.10 suggests a bound
on the out-of-plane deformation, under the assumption that it is similar to that which is
observed within the 2D TRUS images. Finally, because we quantified the tissue
deformation for a large number of biopsies (190) taken during clinical sessions, our inplane deformation quantifications are on a representative sampling of differently
positioned and oriented prostate tissue cross sections imaged by 2D TRUS.
We calculated the TRE using the fiducials located by a single observer over
multiple days. One limitation of this approach is that inter-observer variability in fiducial
localization is not taken into account. As a step toward assessing this limitation, a second
observer located 64 fiducials of four patients five times on five different days. The
measured FLE of the second observer (0.09 mm) was similar to that of the first observer
(0.12 mm), suggesting that inter-observer variability in fiducial localization may not be a
dominant factor.
In order to evaluate the tested registration algorithms and incorporate
measurement error into our tissue deformation estimates, we computed a single TRE for
each algorithm based on multiple fiducials localized in images of several patients. This
approach makes the assumption of a spatially uniform TRE that is invariant to differences
between subjects. Although it is theoretically possible to calculate a separate TRE for
each subject, each biopsy sequence, and even (via TRE interpolation) each pixel of each
registered image pair, such calculations require a sufficiently regular and dense
distribution of intrinsic fiducials (calcifications) in every image in order to robustly
estimate a spatially-varying TRE for every image pair. With an average of 6.2 naturally
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occurring calcifications appearing in each of our tested images, the robustness of an
estimate of a spatially-varying TRE for each image is questionable. This motivated the
computation of an overall TRE based on 390 fiducials across multiple patients, under the
above assumptions.
Another limitation of this work concerns the assumption of the independence of
uncertainties in Equation 2.4. Since the TRE of a registration algorithm may have some
effect on the standard deviation of the deformation vector fields that it produces, it could
be argued that there may be some dependence between these uncertainties. Since the
strength of the independence assumption is unclear, it is reasonable to consider the effect
on the results if this assumption is not made. In this case, the upper bound on the total
uncertainty is the ordinary sum of the individual uncertainties [16]; i.e., in our case,
𝜎𝑟 (𝑃) would become 𝜎̃𝑟 (𝑃) + 𝑇𝑅𝐸. Using this extremely conservative approach, we
would observe a maximum value of 1.96𝜎1 (𝑃𝑑𝐴 ) = 2.3 mm, occurring at 𝑑 = 0, across
both systems. Consequently, spherical tumours with radius 2.3 mm or more could be
sampled with 95% confidence, under the assumption of zero error elsewhere in the
biopsy system.

2.5 Conclusion
In this work, we utilized deformation vector fields given by the symmetric forces
Demons non-rigid image registration algorithm to quantify the deformation of prostate
tissue that occurs during needle insertion and biopsy gun firing. We computed the
coherence of the tissue motion as well as the 95% confidence interval around the amount
of tissue motion, incorporating the measurement error given by the TRE. We calculated
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these statistics in clinically relevant regions of the deformation vector fields in order to
observe trends in the deformation as functions of the distances to the needle axis and
lower piercing point. We also decomposed the deformation and into its lateral and axial
components, and computed the relationship of the deformation to the lateral position of
the needle with respect to the prostate. All of these measurements were used to compare
the conventional hand held approach to a mechanically assisted biopsy system developed
in our laboratory. Overall, we observed a statistically significant, but clinically
insignificant, maximum difference of 0.38 mm in the deformation resulting from the hand
held and mechanically assisted systems along the needle axis. The mechanical system
resulted in a lower relative increase in deformation proximal to the needle axis during
needle insertion, as well as lower variability of deformation during biopsy gun firing.
The results show that for both systems, the tissue deformation is such that throughout the
length of the needle axis, including regions proximal to the lower piercing point,
spherical tumours with radius 2.1 mm or more can be sampled with 95% confidence,
under the assumption of zero error elsewhere in the biopsy system. Along the needle
axis, the deformation was predominantly in the lateral direction; this is of particular
importance given the long, narrow shape of the biopsy core. We measured lateral tissue
motion proximal to the needle axis of not more than 1.5 mm, with 95% confidence.
There was a weak negative relationship between tissue deformation in a local region
around the needle and the lateral position of the needle with respect to the prostate; the
closer was the needle to the center of the prostate, the less was the observed deformation.
Given the clinical need to biopsy tumours of volume greater than or equal to 0.5 cm3,
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corresponding to spherical tumours of radius 5 mm or more, the tissue motion induced by
needle insertion and gun firing contributes to the overall error of the biopsy system
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Chapter 3.
2D-3D rigid registration to compensate for prostate
motion during 3D TRUS-guided biopsy

3.1 Introduction
With the aim of improving the cancer detection rate, systems have been developed [1, 2]
that can plan and record biopsy locations in a 3D TRUS image acquired at the beginning
of the biopsy procedure. Although early reports of these systems are promising, some
limitations have been identified that require attention [3]. For instance, patient motion
and ultrasound probe pressure can cause the prostate to move and deform during the
biopsy procedure. In this chapter, we focus on improving the needle targeting accuracy
of such systems by compensating for prostate motion during the procedure. Target
biopsy locations are usually identified with the assistance of an MR image acquired prior
to the biopsy session, in which cancerous regions are more visible. These locations are
mapped to the 3D TRUS image acquired during the biopsy session to provide guidance
using image information contained in the MR image. The 3D TRUS image can then act
as a baseline image, to guide the physician to the target biopsy locations by augmenting
the 2D TRUS planes acquired during biopsy with 3D contextual information. However,
motion during the procedure could lead to a misalignment between the targets identified
in the initially-acquired 3D image and their corresponding locations within the patient’s
prostate as depicted by the real-time 2D TRUS images acquired throughout the biopsy
procedure. Compensating for the prostate motion and deformation by registering the pre79

acquired 3D image to the live 2D images acquired throughout the procedure is an
important step toward improving the targeting accuracy.
Previous approaches to compensation for prostate motion during biopsy have
involved mechanical stabilization of the ultrasound probe, 3D tracking of the probe, and
the use of biplanar or 3D transducers to continuously acquire richer image information
supporting software-based motion compensation algorithms [1-5]. The mechanically
assisted 3D TRUS-guided biopsy system developed in our laboratory and described in
detail in [1], uses a passive mechanical arm to track the position and orientation of the
ultrasound probe during the biopsy procedure. The design yields a remote centre of
motion positioned at the centre of the ultrasound probe tip that provides enhanced
stability to the US probe minimizing prostate motion. Several methods have been
proposed in similar 3D TRUS-guided biopsy systems to register real-time TRUS images
during the procedure to an initially acquired 3D image [2, 4, 5]. The 3D TRUS-guided
biopsy system presented in Xu et al. [2] uses a magnetic tracking method to locate the
ultrasound plane and it then performs an intermittent rigid registration to compensate for
out-of-plane prostate motion; the registration is invoked when misalignment is detected
visually by an operator. The magnetic tracker transform provides an initialization for the
2D US plane within the world coordinate system in their system. In that work, however,
registration accuracy was measured with a phantom study. Baumann et al. [5] presented
a method relying on the simultaneous real-time acquisition of dual, orthogonal 2D TRUS
images acquired from a 3D ultrasound probe. The same authors presented an algorithm
[4] to compensate for motion using 3D TRUS volumes acquired continuously throughout
the biopsy session. This system does not use any method to track ultrasound probe
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motion; therefore, it relies only on the image information for tracking and uses a coarseto-fine image-based approach to limit the search space during optimization. In addition,
this approach requires a special 3D ultrasound probe with enhanced functionality that
could simultaneously acquire orthogonal 2D TRUS planes and image acquisition occurs
at a lower frame rate, compared to more conventional 2D TRUS. Moreover, compared to
2D TRUS images, orthogonal 2D planes deliver considerably more spatial information;
registration of a single 2D TRUS plane to a 3D TRUS image is a more challenging
problem.
Previous work [6] has assessed the registration accuracy of several algorithms
intended to register two intra-session 3D TRUS images. Although the reported
registration errors in [6] are within a clinically acceptable range, using this method within
the clinical workflow would require stopping the procedure and acquiring an additional
3D TRUS image each time prostate motion correction is required, leading to questionable
feasibility of clinical implementation. Registration of real-time 2D TRUS images to the
pre-acquired 3D TRUS image enables motion compensation without adding extra 3D
image-acquisition time (approximately a minute using 3D TRUS system in [1]) to the
biopsy protocol, and without requiring the use of a 3D TRUS probe. To the best of our
knowledge, no previous work has described and evaluated on human clinical images a
method for the registration of 2D TRUS to 3D TRUS images for prostate motion
compensation during biopsy. Such a technique, if properly validated, will make it
possible to perform prostate motion compensation on 3D biopsy guidance systems that
use readily available 2D ultrasound probes for live image acquisition throughout the
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procedure, permitting more widespread use of targeted biopsy systems and thus greater
potential impact on the patient population.
2D-3D registration methods have been applied to several other interventional
applications in image-guided procedures and Markelj et al. [7] contains an excellent
review. Birkfellner et al. [8] compared the performance of several image similarity
measures and optimization techniques for 2D-3D registration of fluoroscopic images and
found that cross-correlation is an optimal metric for intra-modality matching. In addition,
the parallelizability of the computation of the cross-correlation metric in an intra-modal
registration could be used improve the speed of execution to become useful in a clinical
setting. Wein et al. [9] presented a method to compensate for respiratory motion during
abdominal biopsies and ablations under ultrasound guidance, optimizing local normalized
cross-correlation using the Powell-Brent direction search technique. Although these
previous successes speak to the potential feasibility of addressing the issue of prostate
motion compensation in software using a 2D-3D intensity-based image registration
technique, prostate appearance on TRUS and motion characteristics during biopsy may
differ from those of other organs due to different tissue stiffness properties and flexibility
of surrounding anatomical structures. In this work, our objective is to develop and
evaluate a 2D TRUS-3D TRUS intensity-based image registration technique to
compensate for prostate motion with sufficient accuracy and speed to be translated to
clinical use for 3D biopsy guidance.
This work describes three primary contributions: (1) We present an intensitybased registration algorithm to register 3D TRUS images acquired at the start of the
biopsy procedure to 2D TRUS images acquired during the procedure before the physician
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fires the biopsy gun. We evaluated the performance of the registration algorithm both in
terms of accuracy and speed, after using a GPU-accelerated implementation. The
accuracy of the algorithm was measured using manually identified intrinsic fiducials
within the prostate. (2) We performed the registration for 2D TRUS images acquired
every second throughout the biopsy procedure in order to evaluate registration accuracy
in a scenario when prostate motion is compensated continuously using software, without
requiring any human input to trigger the algorithm. This continuous process was
executed in parallel with other software providing the user interface and thus the
continuous execution of this registration procedure was transparent to the user. At every
one-second interval, we incrementally transformed the baseline 3D TRUS image
according to the registration obtained during the interval. (3) We further validated the
algorithm using a set of 3D TRUS images that were obtained with different levels of
controlled probe pressure. 3D TRUS images were sampled to obtain representative 2D
TRUS images with different amounts of prostate motion and deformation. This data set
contained images with intentionally introduced motion and deformation of magnitudes
intended to challenge the algorithm. In addition, the availability of the 3D information
yielded more intrinsic fiducials for validation. In this work, we also studied the
correlation between image similarity metric values and the amount of misalignment in the
prostate.
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3.2 Materials and methods
3.2.1 Data acquisition
We acquired images from human clinical biopsy procedures using a mechanically
assisted 3D TRUS-guided biopsy system [1] in a study approved by the Human Research
Ethics Board of Western University. The system, using a commercially available endfiring 5-9 MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA), acquired
a 3D TRUS image at the beginning of the biopsy procedure, and then acquired and
displayed 2D TRUS images at a video frame rate (7-30 frames per second) during the
biopsy session. The mechanical encoders attached to the ultrasound probe tracked its 3D
position and orientation throughout the procedure. Using this system, we recorded
images acquired during clinical biopsy procedures under two different protocols, in order
to obtain data sets to test the robustness of the registration algorithm under different
motion characteristics of the prostate. For both protocols, all 3D TRUS images were
recorded prior to taking any biopsy tissue samples. For the first protocol (henceforth
referred to as the biopsy protocol), we acquired images from eight patients. Following
the standard operating procedure for 3D TRUS-guided biopsy in our trial, a 3D TRUS
image was acquired at the start of the biopsy procedure. From the sequence of images
that followed at video frame rate (10-30 frames per second) during the procedure, we
recorded live 2D TRUS images at one frame per second. For the second protocol
(henceforth referred to as the probe pressure protocol), images were acquired from ten
patients. 3D TRUS images were acquired after applying three different probe pressures
on the prostate gland centrally: 1) applying a medium probe pressure, similar to what the
physician usually applies during a biopsy, 2) applying a low probe pressure that caused
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minimal prostate displacement, and 3) applying a high probe pressure that caused
substantial prostate deformation and anterior displacement. This yielded a data set with
prostate displacements and deformations under a wide range of ultrasound probe
pressures.

3.2.2 2D-3D registration – biopsy protocol
For each of the eight subjects, we selected 1–3 2D TRUS images per patient 1–2 seconds
prior to biopsy needle insertion from the 10-12 biopsy samples taken during the biopsy.
This choice of 2D TRUS images was motivated by the fact that accurate alignment of the
predefined targets with the intra-procedure anatomy is chiefly required immediately prior
to biopsy, when a tissue sample is to be taken from an intended biopsy target. We
analyzed 16 such images from eight patients.
The transformation, 𝑇𝑇𝑟 ∶ 𝛹 → 𝛺, given by encoders on the joints of the linkage
of the mechanical assisted 3D-TRUS biopsy system [1], maps each live 2D TRUS image,
𝐼𝑙𝑖𝑣𝑒 ∶ 𝛹 → ℝ, to the world coordinate system of the previously acquired 3D TRUS
image 𝐼𝑏𝑎𝑠𝑒 ∶ 𝛺 → ℝ, where 𝛹 ⊂ ℝ2 and 𝛺 ⊂ ℝ3 . Within the 3D world coordinate
system, any differences in prostate position and orientation between the real-time 2D
TRUS images and the initially-acquired 3D TRUS image are due to prostate motion
within the patient, gross movements of the patient during the procedure, and the biopsy
system’s tracking errors. The accuracy of the initialization for the prostate motion
registration algorithm is based in part on tracking errors of the biopsy system. In the
system developed by Bax et al. [1], the accuracy in delivering a needle to a biopsy core in
a phantom were found to be 1.51 ± 0.92 mm. Registration of live 2D TRUS images to
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the pre-acquired 3D image compensates for both the tracking errors and errors due to
prostate and patient motion.
Live 2D image
𝐼𝑙𝑖

Tracker
transform 𝑇𝑇𝑟

Transform to 3D
space

Transformed 2D
image Ī𝑙𝑖

Baseline 3D
image 𝐼 𝑠

2D 3D
registration

Fiducials

Registration
transform 𝑇

Transform 3D
image

TRE calculation

Figure 3.1:2D-3D registration workflow

The overall workflow in our method is depicted in Figure 3.1. Using the
mechanical tracker transform (𝑇𝑇𝑟 ) we transform 𝐼𝑙𝑖𝑣𝑒 to the 3D world coordinate system.
Registration is then performed to 𝐼𝑏𝑎𝑠𝑒 within this coordinate system. To reduce the
effects of speckle, anisotropic diffusion filtering [10] (conductance parameter = 2, time
step = 0.625) of images was used as a pre-processing step. Although there can be nonrigid deformation of the prostate due to ultrasound probe pressure [6], a rigid alignment
can be found with lower computational cost, so we investigated the accuracy of rigid
registration in this work to determine whether rigid registration is sufficient for the
clinical purpose of biopsy targeting. For each 2D TRUS image, finding the
corresponding plane in the pre-acquired 3D TRUS volume is a 2D-to-3D intra-modality
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rigid registration problem. Due to limited ultrasound contrast within the prostate, reliable
extraction of the boundary and other anatomic features is challenging. Therefore, we
tested an intensity-based registration algorithm.
Using the mechanical tracker transform 𝑇𝑇𝑟 , we can position and orient the 2D
TRUS image 𝐼𝑙𝑖𝑣𝑒 within the 3D world coordinate system yielding a 3D image 𝐼̃𝑙𝑖𝑣𝑒 as
𝐼̃𝑙𝑖𝑣𝑒 (𝑇𝑇𝑟 (𝑝1 )) = 𝐼𝑙𝑖𝑣𝑒 (𝑝1 ) where 𝑝1 ⊂ 𝛹.
The registration of the baseline 3D image 𝐼𝑏𝑎𝑠𝑒 to 𝐼̃𝑙𝑖𝑣𝑒 is performed in this 3D
world coordinate system considering 𝐼𝑏𝑎𝑠𝑒 as the source image and 𝐼𝑙𝑖𝑣𝑒 as the target
image. The objective of the registration is to find the transformation, 𝑇 : 𝛺 → 𝛺,
consisting of a six-parameter-vector given by , that aligns anatomically homologous
points in 𝐼𝑏𝑎𝑠𝑒 and 𝐼̃𝑙𝑖𝑣𝑒 . We used normalized cross-correlation (NCC) [11] as the image
similarity metric that was optimized during the registration. For two images 𝐼̃1 and 𝐼2 , we
optimized the objective function defined as:
𝐹 = argmax 𝑁𝐶𝐶(𝐼̃1 , 𝐼2 ; ), where

𝑁𝐶𝐶(𝐼̃1 , 𝐼2 ; ) =

∑𝑝∈𝛺𝑇 (𝐼̃1 (𝑝) − 𝐼̃1̅ )(𝐼2 (𝑇 (𝑝)) − 𝐼2̅ )
1,2

2

2

{(∑𝑝∈𝛺𝑇 (𝐼̃1 (𝑝) − 𝐼̃1 ) ) (∑𝑝∈𝛺𝑇 (𝐼2 (𝑇 (𝑝)) − 𝐼2̅ ) )}
1,2

1
2

(3.1)

1,2

and 𝛺1 and 𝛺2 represent the subspaces of ( 𝛺 ⊂ ℝ3 ) containing the image domains of 𝐼1
𝑇

𝑢
and 𝐼2 , i.e., Ω1,2
= {𝑝 ∈ Ω1 |𝑇 −1 (𝑝 ∈ Ω2 )}.

We optimized the image similarity measure given by 𝑁𝐶𝐶 (𝐼𝑙𝑖𝑣𝑒 , 𝐼𝑏𝑎𝑠𝑒 ) to obtain
𝑇𝑢 for each of the 16 images we acquired. We used Powell’s method [12, 13] to optimize
the six-dimensional search space that includes three translations and three rotations.
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Powell’s method improved the speed of execution, when compared with a gradientdescent-based method during our initial experiments.

3.2.3 Incremental 2D-3D registration for continuous intra-biopsy motion
compensation
The registration to compensate for prostate motion can be performed frequently (e.g.,
once per second) throughout the biopsy procedure, with the frequency of registration
limited by the time required to register a single pair of images. At a given time point
denoted by 𝑡𝑛 (time elapsed in seconds from the start of the biopsy), we initialized the
source image for the nth registration with the transformation matrix obtained from
registrations at previous time points using
𝑡𝑛
𝑇 = ∏𝑡=𝑡
𝑇 𝒕,
0

During the nth registration, we found the parameter vector
𝑁𝐶𝐶 measure for the transformation matrix 𝑇

𝒕𝒏

(3.2)
𝒕𝒏

that gave the optimum

. We performed the registration for the

complete biopsy procedure for the eight patients described in the previous section using
the sequence of live 2D TRUS images recorded every second from the start of the biopsy
procedure.

3.2.4 2D-3D registration – probe pressure protocol
3D TRUS images acquired at different probe pressures can provide additional anatomical
context to enhance the validation of our registration algorithm. We denote images
acquired at low, medium and high probe pressures, respectively, as 𝐼𝑙𝑜𝑤 , 𝐼𝑚𝑒𝑑 , 𝐼ℎ𝑖𝑔ℎ : 𝛺 →
ℝ. We acquired 30 such images from 10 patients.
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We set the image acquired at medium pressure, 𝐼𝑚𝑒𝑑 , as the source image. As our
target image, we selected 2D slices (𝐼̃{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ}) from the 3D images 𝐼𝑙𝑜𝑤 and 𝐼ℎ𝑖𝑔ℎ . For
the 20 registrations performed (using the 30 3D TRUS images) mechanical tracker
transformations (𝑇𝑇𝑟 ) were randomly selected from 16 frames (across 8 subjects in the
biopsy protocol) occurring an average of 1-2 seconds prior to the firing of the biopsy gun
in real biopsy procedures, according to 𝐼̃{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ} (𝑝2 ) = 𝐼{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ} (𝑇𝑇𝑟 (𝑝1 )) where 𝑝1 ⊂
𝛹 and 𝑝2 ⊂ 𝛺.
Hence, the target images are representative of live 2D TRUS images depicting a
situation with minimal prostate motion (slice from 𝐼𝑙𝑜𝑤 ) and substantial prostate motion
(slice from 𝐼ℎ𝑖𝑔ℎ ). Since the physician intentionally applies different levels of pressure
during the acquisition, the set of images contains a wide range of prostate displacements
and deformations that are intended to represent the extremes of probe pressure during the
biopsy procedure to challenge the registration algorithm. For each subject, we perform
registration between images 𝐼𝑚𝑒𝑑 -𝐼𝑙𝑜𝑤 and 𝐼𝑚𝑒𝑑 -𝐼ℎ𝑖𝑔ℎ by respectively optimizing the
image similarity measures, 𝑁𝐶𝐶(𝐼̃𝑙𝑜𝑤 , 𝐼𝑚𝑒𝑑 ) and 𝑁𝐶𝐶(𝐼̃ℎ𝑖𝑔ℎ , 𝐼𝑚𝑒𝑑 ) as defined above in
Equation 3.1.

3.2.5 Validation
3.2.5.1 Biopsy protocol registration
The registration was validated using manually-identified corresponding intrinsic fiducial
pairs (micro-calcifications) [6]. For the images acquired under the biopsy protocol,
fiducials appearing in 𝐼𝑏𝑎𝑠𝑒 , denoted by 𝑓𝑏𝑎𝑠𝑒 , and the corresponding fiducials from 𝐼𝑙𝑖𝑣𝑒 ,
denoted by 𝑓𝑙𝑖𝑣𝑒 , were identified (𝑓𝑙𝑖𝑣𝑒 ⊂ 𝛹 and 𝑓𝑏𝑎𝑠𝑒 ⊂ 𝛺). We identified 52 fiducial
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pairs for 16 biopsies in eight patients. These fiducial pairs were used for validation only
and were not provided as input to the registration algorithm. Fiducial localization error
(FLE) has been reported in previous studies in the context of 3D TRUS and 2D TRUS
images. The FLE in 3D TRUS images was reported to be 0.21 mm [6] and in 2D TRUS
images was 0.11 [14] mm. The target registration error was calculated as the root mean
square (RMS) error

𝑇𝑅𝐸𝑏 = √

(3.3)

2

𝑁

𝑘
𝑘
𝑘 (𝑇 −1 (𝑓
𝑏
∑𝑘=1
𝑙𝑖𝑣𝑒 )− 𝑇 (𝑓𝑏𝑎𝑠𝑒 ))
𝑇𝑟

𝑁𝑘

,
(3.4)

𝑁

𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 = √

𝑏 𝑇𝑅𝐸 2
∑𝑏=1
𝑏

𝑁𝑏

,

where 𝑁𝑏 is the number of biopsies and 𝑁𝑘 is the number of fiducials identified for a
particular pair of images. The TRE was estimated by first calculating RMS values 𝑇𝑅𝐸𝑏
using the fiducials identified in each pair of images for each biopsy and then calculating
the RMS value 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 for the number of biopsies performed. This approach averaged
the contributions to the TRE from the variable number of fiducials manually identified in
each pair of images during a biopsy. The pre-registration error was calculated without
applying the registration transform 𝑇 in Equation 3.3 to compare against TRE post
registration to assess the improvement.
We selected images that contained visible micro-calcifications within the prostate
in calculating 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 ; an ideal registration algorithm would bring these homologous
landmarks into alignment after registration. Although the fiducials are small (less than
~1 mm radius) by comparison to the size of the prostate and field of view (Figure 3.2
depicts some sample fiducials that we identified), in principle it is possible that the
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presence of the calcifications could guide an intensity-based registration algorithm to a
result giving a lower 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 than would be obtained if the fiducials were not present
in the images. In order to test if the presence of micro-calcifications drive the registration
algorithm to a more accurate solution, we defined masks over the identified fiducials in
both the target and source images and performed the registrations described in the biopsy
protocol registration, restricting the calculation of the image similarity metric to regions
outside of the masks; i.e., to regions not containing the fiducials. Thus, in this
experiment, the registration algorithm was blinded to the presence and locations of the
fiducials. The masks were defined as spherical regions with 1 mm radius in order to fully
cover the largest fiducial markers we observed in our data set.

Figure 3.2: Sample fiducials identified.

3.2.5.2 Probe pressure protocol registration
In the data set acquired under the probe pressure protocol, full 3D anatomical information
for the whole prostate was available for both the source and target images. We manually
identified 188 fiducials throughout the 3D volumes obtained from 10 subjects, without
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limiting the fiducials to lie within the particular extracted plane used in the registration.
The TRE was computed as
2

𝑁

𝑇𝑅𝐸𝑝 = √

𝑘
𝑘
𝑘 (𝑇
𝑏
∑𝑘=1
3𝐷−𝑤𝑜𝑟𝑙𝑑 (𝑓𝑚𝑒𝑑 )− 𝑇𝑢 (𝑓{𝑙𝑜𝑤,ℎ𝑖𝑔ℎ} ))

𝑁𝑘

,

(3.5)

𝑁𝑝

∑𝑏=1 𝑇𝑅𝐸𝑝 2

𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 = √

𝑁𝑝

,

(3.6)

where 𝑓{𝑚𝑒𝑑,𝑙𝑜𝑤,ℎ𝑖𝑔ℎ} ⊂ 𝛺 are the fiducials identified in 𝐼𝑚𝑒𝑑 , 𝐼𝑙𝑜𝑤 , 𝐼ℎ𝑖𝑔ℎ .
We also computed the optimal rigid alignment using the identified fiducials to
define the rigid transformation that yielded the minimum TRE for the given fiducials per
patient. To do this, we found the fiducial registration error (FRE) [15] for each set of
fiducial pairs in each patient, after transforming the fiducials with the parameters
corresponding to the best rigid alignment. With the presence of non-rigid deformations
in the probe pressure protocol data set, the FRE gives a lower bound on the 𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒
that can be obtained using a rigid registration. In a sense, the FRE gives an indication of
the amount of non-rigid deformation present in the data set; e.g., an FRE of 0 mm would
indicate that a rigid transformation could fully compensate for the observed changes in
the prostate, and an FRE > 0 mm would indicate that some amount of non-rigid
deformation may have occurred in the prostate. Thus the FRE gives some indication of a
“best-case” TRE that could be obtained from a registration algorithm using a rigid
transformation and it is therefore of interest to compare the FRE to the 𝑇𝑅𝐸𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒
obtained from our registration algorithm.
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We used the fiducials throughout the prostate to calculate the TRE. To test
whether the TRE varies with distance to the registration plane, we plotted TRE against
the distance to the registration plane for each fiducial.

3.2.6 GPU implementation
The step consuming the most computation time during execution of the registration was
the calculation of the image similarity metric during optimization. Therefore, we
implemented the 𝑁𝐶𝐶 calculation on an nVidia GTX 690 (Nvidia Corporation, Santa
Clara, CA) graphics processing unit (GPU) using compute unified device architecture
(CUDA) C++. The normalized cross-correlation calculation is inherently parallelizable.
Instead of using a sequential approach to transform each voxel independently, we
transformed all voxels in the moving image in parallel during each iteration of
optimization. These transformations were followed by 3D linear interpolation of image
intensities to resample the moving image that was also performed within the GPU. The
subsequent calculation of the summations in Equation 3.1 was also done in parallel to
further accelerate the execution.

3.2.7 Correlation between image similarity metric and misalignment
During registration, we optimize an image similarity metric over a 3D transformation
space. The relationship between the image similarity metric and the amount of
misalignment not only conveys the suitability of the metric to be used in registration, but
also it shows whether the image-similarity metric could be used as an indicator of the
misalignment. This could be a useful feature to trigger the registration algorithm in a
system that does not continuously compensate for motion as during biopsy. To analyze
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this relationship using the biopsy protocol data, we plotted the calculated normalized
cross-correlation measures for each instance before registration, during registration (for
each iteration during the optimization) and after registration (after the optimizer
converged) and their corresponding 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 values.
With manually identified fiducials, we should be able to find a plane within the
3D TRUS image that yields zero (or near zero) TRE. We analyzed the behaviour of
normalized cross-correlation near this “optimum” plane by extracting 2D images lying
nearby (in terms of the six parameters, , defining 3D translation and rotation) planes in
the 3D TRUS image, and computed the image similarity metric for the 2D TRUS image
and these nearby 2D images from the 3D TRUS image. Although this approach does not
fully explore the six-dimensional objective function, to simplify the visualization of the
results, we analyzed the metrics by varying one degree-of-freedom at a time.

3.2.8 TRE as a function of distance to the probe tip
We analyzed the TRE as a function of distance of each fiducial to the ultrasound probe
tip, to test if the registration error is larger within the regions of the prostate close to the
ultrasound probe. Since we used a rigid transformation during registration, non-rigid
deformation of the prostate would be reflected as part of the TRE. Ultrasound probe
pressure might cause inconsistent deformation in different regions of the prostate, which
could lead to regionally-varying accuracy of motion compensation by a rigid
transformation.
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3.3 Results
3.3.1 Validation: biopsy protocol data
The 𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 was calculated according to Equation 3.4 and its RMS±std. was found to
be 1.87 ± 0.81 mm, after manually localising 52 fiducial pairs over 8 patients. This was
an improvement over 4.75 ± 2.62 mm before registration. Since these TRE distributions
were found to be not normally distributed using one-sample Kolmogorov-Smirnov test
with a significance level p < 0.0001, we tested the null hypothesis that their medians were
equal with a non-parametric test using Prism 5.04 (Graphpad Software Inc., San Diego,
USA). The Wilcoxon signed rank matched pairs test rejected the null hypothesis (p <
0.0001) suggesting that there is a statistically significant difference in TREs before and
after registration. When the registrations were performed with the fiducials masked out,
the TRE was found to be 1.93 ± 0.66 mm. When compared with the distribution of
𝑇𝑅𝐸𝑏𝑖𝑜𝑝𝑠𝑦 , the Wilcoxon signed rank matched pairs test failed to reject the null
hypothesis (p = 0.74). Thus, we were unable to detect a statistically significant difference
between the TREs resulting from registrations where the fiducials were present and
registrations where the fiducials were absent.
When 2D-3D registration was performed incrementally every second during the
biopsy, the RMS ± std TRE was reduced to 1.63 ± 0.51 mm. The mean number of
iterations required for convergence decreased from 5.6 to 2.75. Figure 3.3 shows
changes in TRE values before registration, after registration and after registering the
frame obtained every second for each biopsy taken. Figure 3.4 contains two
representative example images, depicting the visual alignment qualitatively for
registration just prior to biopsy. The post-registration TRE of these two example images
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were found to be 1.5 mm (top row) and 1.2 mm (bottom row), which had improvements
from 3.7 mm (top row) and 5.3 mm (bottom row) before registration. Grid lines overlaid
at corresponding locations in image space facilitate visual evaluation of the alignment of
the anatomy pre- and post-registration.
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Figure 3.3: TRE before registration, after registration and after continuous registration every second for
each biopsy in prostate biopsy protocol.
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Figure 3.4: Images before and after registration immediately prior to taking a biopsy sample. Left column:
Real-time 2D TRUS images. Middle column: Corresponding images before registration assuming no
prostate motion (from the transformation given by the mechanical tracking system). Right column:
Corresponding images after registration.
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Figure 3.5: TRE as a function of time elapsed from the start of the biopsy. (a) TRE before registration. (b)
TRE after registration. (c) TRE after registering the images acquired every second.

In order to see the effect of patient motion over time during the biopsy session, we
analyzed the TREs obtained from eight patients as a function of time elapsed since the
start of the biopsy. According to the results shown in Figure 3.5, it can be seen that the
TRE values before and after registration have an increasing trend with the elapsed time
during the biopsy. Weak relationships were found with slopes of the best-fit line 10 µm/s
(correlation coefficient (r2) = 0.23) before registration and 4 µm/s (r2 = 0.41) after
registration. When the registration was performed every second, the slope of best-fit line
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was found to be 2 µm/s (r2 = 0.37). We also calculated the slopes of the best-fit lines to
plots of TRE versus time elapsed during biopsy for each individual patient, and then
calculated the mean and standard deviation of these observed slopes in scenarios with and
without the use of motion-compensating registration. Without registration, we observed
a mean±std slope of 14±15 µm/s. With registration, we observed a mean ± std slope of
7±10 µm/s, and 5±14 µm/s with continuous registration.

3.3.2 Validation: probe pressure protocol data
The RMS TRE for the data acquired under the probe pressure protocol was 3.18 ± 1.6
mm. This was an improvement from a 6.89 ± 4.1 mm TRE before registration. Note that
we used the fiducials in the whole prostate (not just the slice containing the fiducials) in
TRE calculation as given in Equation 3.6. The mean value for the FRE, corresponding to
the best rigid transform that aligns the identified fiducials, was found to be 1.85 ± 1.2
mm. The distribution of TRE values before registration, after registration, and after
transforming with the best rigid alignment is shown in Figure 3.6. Table 3.1 contains
TRE calculated separately for 𝐼𝑚𝑒𝑑 -to-𝐼ℎ𝑖𝑔ℎ and 𝐼𝑚𝑒𝑑 -to-𝐼𝑙𝑜𝑤 . Registration between 𝐼𝑚𝑒𝑑
and 𝐼ℎ𝑖𝑔ℎ has resulted in a larger TRE. We also observed higher FRE in 𝐼𝑚𝑒𝑑 -to-𝐼ℎ𝑖𝑔ℎ ,
suggesting a greater amount of non-rigid deformation of the prostate at this extremum of
probe pressure. The error in registration includes the errors due to non-rigid deformation
occurring within prostate regions outside of the 2D target image (as opposed to the errors
arising only due to deformation within the 2D target image as in the biopsy protocol) and
the variability in manually locating the fiducials in 3D. However, according to the
relationship between distance from registration plane to each fiducial and the TRE shown
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in Figure 3.7, we did not observe a strong relationship between the TRE and the distance
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Figure 3.6: Histograms for TRE before and after registration for probe pressure protocol data. Left: TRE
distribution before registration Middle: TRE distribution after registration. Right: TRE distribution with the
best rigid alignment for the identified fiducials.
Table 3.1: Errors before and after probe protocol registration.

𝐼𝑚𝑒𝑑 -to-𝐼ℎ𝑖𝑔ℎ
𝐼𝑚𝑒𝑑 -to-𝐼𝑙𝑜𝑤
Average

Error before registration
(mm)
7.57 ± 4.58
6.12 ± 3.68
6.89 ± 4.12

TRE after registration
(mm)
3.65 ± 2.12
2.65 ± 0.34
3.17 ± 1.60

FRE (mm)
2.12 ± 1.45
1.54 ± 0.68
1.85 ± 1.67
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Figure 3.7: TRE of each fiducial as a function of distance to the registration plane. The black line
represents the least-square fit to the scattered points.
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3.3.3 Speed of execution
After the GPU-accelerated implementation (nVidia GTX 690 GPU card and Intel Core
i7-3820 3.6 GHz processor) the registration was performed with mean ± std times of 1.1
± 0.1 seconds for the biopsy protocol experiments described in this paper.
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Figure 3.8: TRE as a function of metric value during the optimization. Initial points (circles), converged
(squares) and converging points (crosses).

Figure 3.9: TRE distributions before registration, during convergence and after registration.

3.3.4 Correlation between image similarity measure and misalignment
Figure 3.8 shows the relationship between the image-similarity measure and values of
TRE for each transformation obtained during the optimization iterations. The circle
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points show the values before registration, and the square points show the values after
registration converged. The cross points depict the values during convergence. The
correlation coefficient (r2), calculated using all points (before, during, and after
convergence) in Figure 3.8, was found to be 0.23. Figure 3.9 shows a box plot of the
TRE distributions of the points before registration, during convergence and after
registration. While the TRE decreases in general during convergence, a weak correlation
can be seen between image similarity measures and TRE from these results.
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Figure 3.10: Mean and standard deviations of normalized cross-correlation values for 16 image pairs of
eight patients in the six-degrees-of-freedom transformation space, one degree-of-freedom varying at a time.
The zero location in the x-axis corresponds to real-time 2D-TRUS frame.
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Figure 3.11: Normalized cross-correlation values for a single image pair of a biopsy for 3 patients (each
biopsy represented by a separate line pattern) in the six-degrees-of-freedom transformation space, one
degree-of-freedom varying at a time. The zero location in the x-axis corresponds to real-time 2D-TRUS
frame.

Figure 3.10 shows plots of the normalized cross-correlation metric versus out-ofplane, in-plane rotations and translations. The solid curves represent the mean values of
the metrics for different out-of-plane rotations and translations for 16 2D TRUS images
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across eight subjects, and the dashed curves show the values one standard deviation
above and below the mean. The convexity of the mean curves gives an indication of the
general capture range of the objective functions for many registrations. Figure 3.11
shows the three plots of normalized-cross-correlation metrics similarly obtained for a
single biopsy in three patients. The generally convex shape of the functions observed in
Figure 3.10 and Figure 3.11 encourages the use of normalized cross-correlation during
registration in compensating for prostate motion.

3.3.5 TRE as a function of distance to the probe tip
Figure 3.12 shows TRE as a function of the distance to the probe tip for each individual.
The TRE tends to increase closer to the probe tip (r2 value = 0.1); however, the
correlation between distance to the probe tip and the TRE before registration is weak.
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Figure 3.12: TRE as a function of distance to the probe tip.

3.4 Discussion
3.4.1 Accuracy of registration
Our image registration method was validated using the fiducials identified in clinical
images acquired during the biopsy procedures. There was a significant improvement of
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TRE after registration in both biopsy and probe pressure protocols. The required
accuracy of the biopsy system to guide needles to target locations stems from the size of
the smallest clinically-relevant tumours (0.5 cm3, corresponding to a spherical target with
5 mm radius) [16, 17]. A biopsy system with a measured RMS error of 2.5 mm in taking
a sample from the intended target will have a probability of at least 95.4% of taking a
sample within this 5 mm radius since 5 mm is 2 standard deviations away from the mean
of the distribution of targets given by an system with RMS error of 2.5 mm [6]. An
image-based registration during the procedure, while compensating for prostate motion,
also corrects for tracking errors in the biopsy system, if any. Therefore, if the registration
was performed immediately before the physician fires the biopsy gun to capture a tissue
sample from the prostate, the targets identified in the pre-acquired 3D image would be
aligned with the live 2D TRUS image, with accuracy limited by the TRE of the
registration algorithm. However, the motion and deformation induced due to the rapid
firing of the biopsy gun, which happens during a sub-second interval remains an error in
the biopsy system that is challenging to correct. When targeting a predefined location,
the TRE of the motion compensation algorithm and the error during the rapid biopsy-gun
firing process, which was quantified in [14] to be an error with 95% confidence interval
less than 2.1 mm, may accumulate and become an important consideration.
Alignment of the targets identified in the 3D TRUS image to the live 2D TRUS
image is primarily required immediately before the physician fires the biopsy gun.
Consequently, this registration could be integrated into the clinical workflow by
executing it just prior to the physician aiming at target locations. However, according to
the results, both the accuracy and speed of the registration were improved when the
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registration was performed on the 2D TRUS images acquired every second.
Initializations obtained by placing 2D TRUS images within the 3D coordinate system
using the mechanical tracker transform (𝑇𝑇𝑟 ) might further improve when the baseline 3D
TRUS image is updated more frequently with the transforms from registrations
performed every second. This may help the algorithm in faster convergence to a suitably
accurate optimum. Therefore, in a clinical procedure, this algorithm can be performed in
the background continuously compensating for motion.

3.4.2 Change of TRE with time during biopsy
The weak positive relationship between TRE and time elapsed shown in Figure 3.5(a),
suggest that the misalignment between pre-acquired and live images increases with time
(slope of the best-fit line = 10 µm/s, mean±std = 14±15 µm/s for individual patients).
After performing the registration just before a biopsy sample is taken, there is still a
positive relationship (slope = 4 µm/s, mean±std = 7±10 µm/s) between TRE and time.
This indicates that image pairs, with higher initial misalignments towards the end of the
biopsy procedure, were more challenging for the algorithm. In Figure 3.5(c), the slope of
the best-fit line was lower (slope = 2 µm/s, mean±std = 5±14 µm/s) when the
registrations were performed every second. Thus, although the TRE does appear to
increase with time even when registration is applied, this effect is less pronounced
compared to the no-registration scenario. The increasing trend in TRE with time that we
observe for eight patients in Figure 3.5(c) even when the motion was being compensated
every second could be due to accumulation of registration errors during continuous
registration. In addition, the swelling and deformation of the prostate caused by the
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increasing number of needles being inserted might increase the challenge to the algorithm
as a function of time elapsed since the start of the biopsy.

3.4.3 Probe pressure protocol
The TREs from the probe pressure protocol are surrogate measures of the absolute total
registration error that could be observed under extreme prostate deformations during
prostate biopsy. In probe pressure protocol, the TRE was 1.2 mm higher than that of the
biopsy protocol. This increase could be attributed to the use of fiducials from the whole
prostate during validation. The best rigid transform for the selected plane may not
necessarily be the best rigid fit for the whole prostate due to non-rigid deformations
occurring at different (out of plane) regions of the prostate. Moreover, the high probe
pressures intentionally exerted by the physician when acquiring these images might have
caused more than the usual deformation that occurs during biopsy. The extreme range of
probe pressures and prostate displacement and deformation could make accurate
registration more challenging as the algorithm is more susceptible to local optima the
further the initialization is from target alignment. In addition, substantial non-rigid
deformation may result in higher TREs from rigid registration algorithms when high
probe pressure is applied to the prostate. Whereas the prostate deformations occurring
during the biopsy protocol arise from real clinical biopsy sessions, the probe pressure
protocol was explicitly designed to test the performance of the algorithm at the extrema
of non-rigid deformations that can be reasonably applied to the patient's prostate in vivo,
without consideration of the plausibility of such deformations occurring in a clinical
biopsy context. The outliers observed in Figure 3.6(c) suggest that a non-rigid
transformation may be useful in correcting for the more extreme deformations applied
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during the probe pressure protocol. This is illustrated quantitatively in the FRE column of
the first row of Table 3.1, where registration errors involving high probe pressure were
separately analyzed. However, the fiducial identification process was relatively more
straightforward due to the availability of 3D contextual information in both the fixed and
moving images.

3.4.4 Correlation between similarity metric and TRE
Figure 3.8 shows a weak correlation between similarity metric values before, during and
after convergence and the TRE. We can observe for the cases where the metric values
were greater than -0.9, the TREs were greater than 3.5 mm. Furthermore, the generally
convex shapes observed in Figure 3.10 and Figure 3.11 in metric values as a function of
different amounts of introduced translations and rotations, suggest that the metric value
could be used as a weak indicator to the quality of the registration.
In Figure 3.12, a weak negative correlation can be seen between the TRE and
distance to the probe tip. This suggests that near the probe tip there could be higher nonrigid deformation of the prostate that may not be accurately compensated with a rigid
registration algorithm. However, given the limited sample size and the weak relationship
observed, further verification is required to attribute the negative correlation to the
presence of non-rigid deformation.

3.5 Conclusions
Accurate and quick registration to compensate for motion during biopsy is an important
step to improve the accuracy in delivering needle to target locations within the prostate.
We presented a 2D-to-3D rigid intensity-based registration algorithm validated on human
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clinical images using intrinsic fiducial markers, to align a 3D TRUS image (with
associated prostate biopsy targets) acquired at the start of the procedure to 2D TRUS
images taken immediately prior to each biopsy during the procedure. We also presented
evidence that image similarity metrics can be used as a weak indicator of the amount of
prostate misalignment (with respect to the initially acquired 3D TRUS image), and could
be used to trigger the execution of a registration algorithm when necessary. Using our
high-speed GPU implementation (1.1 seconds total time per registration), this algorithm
has the potential to be useful during the clinical workflow of a biopsy procedure.
Although 2D-3D registration methods described in this paper yielded statistically
significant improvements in accuracy, the RMS TRE was found to be 3.18 ± 1.6 mm with
the 3D TRUS data set acquired under a more controlled range of probe pressures
intending to thoroughly test the algorithm, Therefore, achieving a more accurate and
robust registration for motion compensation could be helpful to meet the clinical
requirements of accurately targeting smallest clinically significant tumors using 3D
TRUS-guided biopsy systems.
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Chapter 4.
Evaluating the utility of intra-procedural 3D TRUS image
information in guiding registration for motion compensation
during prostate biopsy

4.1 Introduction
With the objective of improving the cancer detection rate during biopsy, systems have been
developed to perform a targeted biopsy by fusing pre-biopsy MRI with 3D TRUS [1-6]. In many
such systems, prior to performing biopsy, suspicious lesions delineated as targets in a pre-biopsy
MR image are mapped to the static baseline 3D TRUS image acquired at the beginning of the
biopsy session [7-10]. Biopsy is subsequently performed, targeting each suspicious lesion using
the live 2D TRUS images acquired while tracking the ultrasound probe position and orientation
relative to the baseline 3D TRUS image. However, patient or prostate motion during the
procedure causes misalignments in the targets mapped to the live 2D TRUS images from the
baseline 3D TRUS image.
While 2D TRUS images are widely used for intra-procedural guidance, some solutions
utilize richer intra-procedural images such as bi- or multi-planar TRUS or 3D TRUS, acquired
by specialized probes. Multiple algorithms have been proposed to perform software-based
motion compensation by registering intra-procedural TRUS images to an initially acquired 3D
TRUS image [1, 2, 5, 11]. However, intra-procedural image acquisition and initialization within
the 3D coordinate system prior to registration are quite different in each method. The system
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proposed in Baumann et al. [1] used a GE Voluson endorectal RIC5-9 probe (GE Healthcare,
United States) to acquire 3D intra-procedural images to perform image-based tracking to
compensate for motion. The 3D intra-procedural image acquisition time in that system was
reported to be 0.5-5 s depending on the image quality while the subsequent non-rigid registration
consumed an additional 7-8 s. In Baumann et al. [2], the authors described a similar registration
approach using simultaneously acquired dual-orthogonal frames from a 3D TRUS probe as the
intra-procedural images. Xu et al. [5] performed the registration after initializing several
previous 2D TRUS frames in a 3D coordinate system using the transformations provided by a
magnetically tracked probe. In that system, 2D TRUS frames were acquired using a Philips C95 2D TRUS probe (Philips Medical Systems, Seattle, WA) in real-time while the motion
compensation algorithm, with an approximate execution time of 4 seconds, was triggered by the
operator after visual detection of misalignment. De Silva et al. [11] previously performed a 2D3D registration using the initialization provided by a mechanically tracked probe. The
registration was performed in 1.1 seconds following the real-time acquisition of the intraprocedural image using the same conventional 2D TRUS probe (Philips Medical Systems,
Seattle, WA) as in Xu et al. [5]. Both of the systems [5, 11] constructed the baseline 3D TRUS
image at the beginning of the procedure using the 2D images acquired from a ~10 second
rotational sweep of a tracked 2D TRUS probe. In addition, intra-procedure prostate motion has
been identified as a potential problem [12] hindering accurate needle targeting in MR-guided
prostate biopsy systems [13-15]. Solutions [16, 17] have been proposed for motion
compensation by co-registering multi-slice intra-procedural MR images with a pre-acquired MR
image.
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Live intra-procedural images acquired during the biopsy procedure need to be registered
both quickly and accurately to compensate for motion. During registration, we optimize an
image-based similarity metric between pre- and intra-procedural images in a rigid 3D
transformation space. Although prostate deformation due to TRUS probe pressure could be
compensated by a non-rigid registration approach, it is less desirable considering the slower
speed of non-rigid registration in the context of the short duration of the biopsy procedure and
the limited time of effect of the local anesthesia provided to the patient. In addition, achieving a
robust rigid registration is an essential initial step before proceeding to a non-rigid refinement.
Limited anatomical context available in single plane 2D TRUS images could limit the robustness
of the registration, especially considering the rotational symmetry of the prostate, as there can be
multiple ways (i.e., local optima) to orient a single 2D TRUS image within the 3D context that
yield high image similarity values. On the other hand, intra-procedural 3D information in multiplanar or 3D TRUS images provides richer anatomical context than in single plane 2D TRUS;
this could help to improve the accuracy of the registration algorithm. Therefore, by including
additional 3D image planes in the image-similarity metric calculation, the objective function
shape could change due to the additional (or “richer”) anatomical information, in order to
improve the robustness of the optimizer in finding the desired registration solution. However,
both image acquisition and image registration require additional time when using intra-procedure
3D information. Multi-planar or 3D TRUS image acquisition either using probes with enhanced
functionality or via multiple acquisitions by a rotational sweep of a tracked conventional 2D
TRUS probe is slower than that using a near real time conventional 2D TRUS probe. Moreover,
image registration requires more time when using intra-procedural 3D TRUS images to calculate
the image similarity metric values using more intensity samples.
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In order to design a suitable approach to compensate for prostate motion, taking into
account these tradeoffs between accuracy and speed, it is useful to quantify the improvements in
registration accuracy obtained by acquiring different amounts of 3D information in the intraprocedural TRUS images. In this work, (1) we compared the motion compensation accuracies
resulting from the use of several potential intra-procedural imaging approaches, ranging from
single 2D TRUS frames to full 3D TRUS imaging, to evaluate how different amounts of 3D
image information affect the registration accuracy; (2) we analysed how frequently and in which
anatomic regions of the prostate the motion compensation accuracy benefits most from
additional 3D image information acquired during the procedure; and (3) we investigated whether
rigid alignments obtained via image-based registration could achieve accuracies suitable for use
in a clinical setting. Our results could inform the designers of next-generation guided prostate
biopsy systems as to (1) optimal design/selection of ultrasound imaging techniques to be used
intra-procedurally; (2) whether and how to adaptively acquire additional 3D information when
the physician is targeting specific regions of the prostate; and (3) whether to invest effort in the
development of real-time non-rigid registration for prostate motion compensation during the
procedure.

4.2 Materials and methods
4.2.1 Materials
29 patients (mean ± std age: 59 ± 7, PSA: 5.4 ± 2.8 ng/ml, prostate volume: 38.8 ± 20.0 cm3)
were included in this study that was part of a larger human subjects research ethics board
approved MRI-3D TRUS fusion biopsy study. The 3D TRUS images were collected in advance
of the scheduled biopsy as part of our institution’s standard protocol to fuse MRI to pre-biopsy
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3D TRUS images. 3D TRUS images were acquired with a mechanically tracked 3D TRUSguided biopsy system described in Bax et al. [3], using a commercially available end-firing 5-9
MHz HDI 5000 TRUS transducer probe (Philips Medical Systems, Seattle, WA). During 3D
TRUS image reconstruction, a set of 2D TRUS images was acquired by a 180 degree probe-axial
rotation of the otherwise stationary TRUS probe (i.e., the entire probe is rotated, including its
outer surface) and then resampled the resulting 2D planes in a 3D grid to obtain the 3D TRUS
image. Each 3D TRUS volume had a grid size of 224 × 224 × 175 voxels, with an isotropic
voxel size of 0.37 mm, and was preprocessed via anisotropic diffusion filtering [18]
(conductance parameter = 2, time step = 0.625) for speckle reduction. Each 3D TRUS image
acquisition required approximately 10 seconds.
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Figure 4.1: (a) Coronal view (from the posterior perspective of the TRUS probe) of relative positions of the probe
tip during image acquisition (B: baseline, 1-6: sextant locations) (b) Transverse view showing the necessary
reorientation of the probe to acquire images at baseline and targets 2 and 5.

A total of 7 3D TRUS volumes were acquired per patient, with the first image acquired
centrally within the gland—corresponding to the typical baseline 3D TRUS image acquired at
the start of most MRI-TRUS fusion biopsy procedures [5, 11]. The six additional 3D TRUS
images were acquired after maneuvering the TRUS probe toward each of the sextant biopsy
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locations. Figure 4.1 shows the relative bilateral sextant biopsy locations in the base, mid-gland
and apex regions of the prostate when acquiring 3D TRUS images by a rotational sweep of the
TRUS probe at each position. The order of sextant 3D TRUS acquisitions was reversed for half
of the patients (the order from 1 to 6 were reversed to 6 to 1 according to the positions shown in
Figure 4.1) in an effort to mitigate possible dependence of prostate motion at each sextant
location to the previous probe position.
Each sextant 3D TRUS image comprises a set of 2D TRUS images that could be acquired
using a conventional 2D TRUS probe when targeting a region in that sextant. The mechanical
encoders attached to the ultrasound probe tracked the 3D position and orientation of the
individual 2D TRUS images acquired during the rotational sweep, yielding a transformation of
every 2D TRUS image to a common 3D world coordinate system. The 7 3D images indicated by
probe positions in Figure 4.1 were acquired from 29 patients, for a total of 203 3D TRUS
images. During registration, surrogate intra-procedural images were extracted from the 3D
TRUS images acquired at the bilateral sextant probe positions that simulated different 3D TRUSguided biopsy scenarios while the 3D TRUS image acquired at the baseline probe position
served as the pre-procedural image.

4.2.2 Image registration
For all registrations, the 3D TRUS image at the baseline position (𝐼𝐵 ) was used as the moving
image to update the target locations in the baseline image to compensate for motion. We used
several different fixed image configurations, ranging from a single 2D TRUS plane to a full 3D
TRUS image; Figure 4.2 lists the notations for the fixed image configurations used in the
registration experiments in this paper, along with a schematic description of each. The fixed
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images extracted from 3D TRUS images at sextant probe positions are denoted as 𝐼𝛼1 ,𝛼2 ,…,𝛼𝑛 ,
where 𝑛 is the number of planes extracted from angles 𝛼, or 𝐼𝛼1 −𝛼2 for all planes between angles
𝛼1 and 𝛼2 ; 𝛼 = 0 denotes the transverse or axial plane. Thus, at one end of a continuum, 𝐼0
indicates the use of a single transverse 2D TRUS image as the fixed image, and at the other end,
𝐼0−179 indicates the full 3D TRUS image. Extracting different planes from the 3D TRUS image
to construct the fixed image (illustrated in Figure 4.2) simulates intra-procedural images for
different intra-procedural scenarios, ranging from monoplanar 2D TRUS imaging [5, 11],
through multi-planar and partial volume imaging [2], to full 3D TRUS imaging [1] conducted
throughout the procedure.
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Figure 4.2: Fixed image configurations used in this paper: notation and schematics of planes from a probe-axis
view.
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Figure 4.3: Overall workflow in methods and validation.

For each fixed image configuration given in Figure 4.2, registration and validation were
performed according to the overall workflow given in Figure 4.3. During image-based
registration, the transformation from the mechanical tracker initialized the subsequent rigid
registration performed by optimizing the normalized cross-correlation [19] (NCC) using
Powell’s method [20] as the optimizer, as described in De Silva et al. [11]. A total of 174
registrations were performed on images of 29 patients (6 registrations per patient) for each
construction of fixed images according to Figure 4.2. For each patient 𝑖 = 1...29 and fixed image
constructions with different probe positions 𝑗 = 1...6 we optimized the objective function given
by normalized cross-correlation as
𝑇 𝑖𝑗 =

𝑖𝑗

𝑟𝑔 max 𝑁𝐶𝐶(𝐼𝛼1 ,..,𝛼2 , 𝐼𝐵𝑖 ; 𝑇̌ 𝑖𝑗 )
𝑖,𝑗

to determine the rigid transformation 𝑇 𝑖𝑗 corresponding to the motion.
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4.2.3 Registration error measurement
Although the patient was in the lateral decubitus position during 3D TRUS image acquisitions,
patient discomfort and TRUS probe pressure can cause prostate motion. Therefore, the
ultrasound probe tracking information cannot be used to determine the motion of the prostate,
since the prostate may have moved relative to the probe. This motion was quantified relative to
manually identified intrinsic fiducials (micro-calcifications) of the prostate. Registration error
was measured as the root mean square (RMS) target registration error (TRE) [21, 22] of
manually identified corresponding pairs of fiducials for every registered 3D TRUS image pair. It
is important to note that the fiducial pairs were identified only to measure the accuracy of
registration and were not provided as input to the registration algorithm. Fiducials were
identified throughout the 3D TRUS images regardless of the planes used for registration and the
𝑖𝑗𝑘

𝑘th fiducial in the fixed image of the 𝑖 th patient in the 𝑗th sextant position is denoted by 𝑓𝐹

and

𝑖𝑗

the fiducials in the moving image by 𝑓𝑀𝑖𝑘 . Using the transformation (𝑇𝛼1 ,..,𝛼𝑛 ) obtained from the
registrations at each fixed image configuration, the RMS TRE was calculated as
𝑖𝑗𝑘

𝑖𝑗

𝑖𝑘 ))2
∑𝑖,𝑗,𝑘(𝑓𝐹 −𝑇𝛼 ,..,𝛼 (𝑓𝑀
𝑛
1
.
𝑁

𝑇𝑅𝐸𝛼1,..,𝛼𝑛 = √

4.2.4 Experimental methods
A total of 1003 fiducial pairs were identified across image pairs of all patients with a mean ±
standard deviation (std) of 5.8 ± 1.2 fiducial pairs per registration. Figure 4.4 shows the
distribution of the identified fiducials projected to Anterior/Posterior (A-P), Left/Right (L-R) and
Inferior/Superior (I-S) planes from the 3D space, with the prostate size normalized from 0 to 1
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along each direction. Figure 4.5 depicts the sample calcification pairs that were identified as the
anatomical landmarks.
Sagittal Projection
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Figure 4.4: Distribution of manually identified fiducials used for registration validation. Each fiducial is shown with
its Anterior/Posterior (A/P), Left/Right (L/R) and Inferior/Superior (I/S) position within the normalized prostate in
which the boundaries extend from 0 to 1 along each direction.

4.2.5 TRE for different fixed image configurations
The RMS ± std TRE was calculated for each registration using the fixed image configurations
defined in Figure 4.2. To provide context for interpretation of these results, the pre-registration
error and the fiducial registration error (FRE) [21] were also calculated. To compare the two
extremes of fixed image information (2D versus full 3D), the distribution of TRE improvements
𝑖𝑗

𝑖𝑗

(𝑇𝑅𝐸0 − 𝑇𝑅𝐸0−179) were calculated when using a full 3D TRUS image as opposed to using a
single 2D TRUS image for motion compensation.
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Figure 4.5: Example of the identified fiducials for three pairs of images. Arrows point to homologous fiducial pairs
in each row. Baseline images with the fiducials are shown in the left and the sextant images of the same patient with
corresponding fiducials are shown in the right.

4.2.6 TRE for base, mid-gland and apex regions
The TRE distributions were analysed separately for mid, base and apex regions of the prostate to
understand the benefit of using additional 3D image planes in each region. The TRE for each
probe position was calculated separately as
𝑖𝑗𝑘

𝑇𝑅𝐸

𝑗

𝛼1,..,𝛼𝑛

∑𝑖,𝑘(𝑓𝐹
=√
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𝑖𝑗

𝑖𝑘 ))2
−𝑇𝛼 ,..,𝛼𝑛 (𝑓𝑀
1
.
𝑁𝑗

To determine an optimal registration error against which to compare the TREs, we
calculated the FRE resulting from the rigid transformation that optimally aligned the intrinsic
fiducials. The FRE was calculated by finding the optimal rigid transformation that yielded the
least squared error for the fiducials in a given image pair as
𝑖𝑗𝑘

𝑖𝑘 ))2
∑𝑘(𝑓𝐹 −𝑇 𝑖𝑗 (𝑓𝑀

√
𝐹𝑅𝐸 𝑖𝑗 = arg min
𝑖𝑗
𝑇

𝑁𝑘

.

4.3 Results
4.3.1 TRE for different fixed image configurations
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Figure 4.6: TRE histograms for registrations using different fixed images, with the RMS ± std TRE shown in the
top left of each histogram. To provide context for the TRE distributions, row 1, column 1 shows the error
distribution prior to registration and row 2, column 1 shows the error distribution after optimal rigid registration
using the fiducials (FRE).

Figure 4.6 shows the RMS ± std TRE for registration using each fixed image configuration
defined in Figure 4.2, along with the pre-registration error and the FRE and the histograms of
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each distribution. Since these TRE distributions were found to be not normally distributed by a
one-sample Komogorov-Smirnov test (p > 0.05), for each pairing of fixed image configurations
we tested the null hypothesis that the paired distributions have the same medians with the nonparametric Wilcoxon signed rank test. The null hypothesis was rejected for each pair of
distributions (p < 0.006) except for the pair of distributions with fixed images as 𝐼0,45 and 𝐼0,135
(p = 0.2). The RMS TRE decreased monotonically with an increasing number of planes included
in the fixed image configuration. The lowest and least variable error was obtained when the
fixed image was selected to be the full 3D image (𝐼0−179 ). Figure 4.7 compares the parameters
of the TRE distributions at different fixed image configurations as a box and whisker plot. To
directly compare the extremes of fixed image configurations, Figure 4.8 shows the histogram of
distribution of TRE error reductions resulting from the use of a 3D fixed image configuration,
𝑖𝑗

𝑖𝑗

compared to a 2D fixed image configuration, calculated as 𝑇𝑅𝐸0 − 𝑇𝑅𝐸0−179 . Figure 4.9
shows qualitative examples of the alignments provided by registration with different fixed image
configurations, for three patients. Mean execution times for registrations with single-plane, biplane, partial-volume, and full 3D volume fixed image configurations are shown in Table 4.1.
The time required increases with more intensity samples used for registration. The times were
measured using a graphics processing unit (GPU) accelerated implementation of the NCC
calculation with NVIDIA GTX 580 (NVIDIA Corporation, Santa Clara, CA) GPU and an Intel
Xeon 2.5 GHz processor (Intel Corporation, Santa Clara, CA).
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Fixed Image

Reg. using I0-90
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Figure 4.9: Corresponding transverse 2D planes from; (a) fixed image, (b)-(d) transformed moving image after
registration using the fixed image configurations as indicated, (e) moving image before registration.
Table 4.1: Mean execution times for registration with different fixed image configurations

*Using

Fixed image configuration

Mean execution time (s)*

𝑻𝑹𝑬𝟎

1.8

𝑻𝑹𝑬𝟎,𝟗𝟎

2.1

𝑻𝑹𝑬𝟎−𝟗𝟎

8.0

𝑻𝑹𝑬𝟎−𝟏𝟕𝟗

14.6

a GPU accelerated implementation for NCC calculation (NVIDIA GTX 580 GPU card and Intel Xeon 2.5 GHz processor)

4.3.2 TRE for base, mid-gland and apex regions
In Table 4.2, we present the average TRE values in base, mid and apex regions of the prostate as
well as TRE separately for each sextant region for two fixed image configurations: single plane
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and full 3D TRUS image. The error before registration as well as 𝑇𝑅𝐸0 using a single plane was
higher in the base and apex regions of the prostate when compared with the mid-gland; for both
distribution pairs, the non-parametric Wilcoxon signed rank test rejected the null hypothesis (p <
0.001) that the paired distributions had the same median. The observed motion during biopsy
movements within the left gland of the prostate was significantly larger (Wilcoxon signed rank
test, p < 0.001) than that of the right gland even though the order of left to right and right to left
acquisitions were reversed for half of the patients during image acquisitions. The additional
𝑗
improvement in TRE (𝑇𝑅𝐸0𝑗 − 𝑇𝑅𝐸0−179
) when using full 3D information as opposed to using a

single plane for registrations, was larger (Wilcoxon signed rank test, p < 0.07) in the base and
apex regions when compared with the improvements obtained in the mid-gland. However, at the
95% confidence level (p = 0.05) there was no significant difference between base, apex regions
and the mid-gland detected.
Table 4.2: RMS ± std TREs for registrations at different sextant probe positions.
𝒋

𝒋

𝒋

𝒋

Sextant position
(𝒋)

Before reg.
(mm)

FRE (mm)

𝑻𝑹𝑬𝟎 (mm)

𝑻𝑹𝑬𝟎−𝟏𝟕𝟗 (mm)

𝑻𝑹𝑬𝟎 − 𝑻𝑹𝑬𝟎−𝟏𝟕𝟗
(mm)

Base

5.3 ±2.6

1.2 ± 0.6

3.4 ±1.8

1.7 ± 0.7

1.7

– Left base

4.6 ± 2.6

1.1 ± 0.5

2.8 ± 1.6

1.5 ± 0.6

1.3

– Right base

5.9 ± 2.4

1.4 ± 0.7

3.9 ± 1.8

1.9 ± 0.9

2.0

Mid

4.1 ± 2.1

0.9 ± 0.4

2.2 ± 1.0

1.3 ± 0.5

0.9

– Left mid

3.0 ± 1.5

1.0 ± 0.4

1.6 ± 0.6

1.3 ± 0.5

0.3

– Right mid

5.0 ± 2.2

0.9 ± 0.3

2.7 ± 1.2

1.3 ± 0.5

1.4

Apex

5.3 ± 2.2

1.2 ± 0.7

3.5 ± 1.9

1.9 ± 1.0

1.6

– Left apex

4.1 ± 1.5

1.4 ± 0.8

3.0 ± 1.4

2.1 ± 1.2

0.9

– Right apex

6.3 ± 2.4

1.2 ± 0.5

4.0 ± 2.3

1.7 ± 0.7

2.3
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4.4 Discussion
In this work, we compared the accuracy and robustness of prostate motion compensation during
TRUS-guided biopsy when varying amounts of 3D image content are available in the live images
used for guidance, ranging from 2D images such as would be acquired from a conventional
monoplanar probe, through bi- and multi-planar images, to full 3D TRUS imaging. The results
could inform the selection of a suitable approach in a clinical setting considering the trade-offs in
accuracy, time and hardware costs. Although 3D information has aided the registration
algorithm in converging robustly to more accurate solutions, image acquisition and registration
requires more time when using such information, and probe costs may increase. In previously
published approaches for 3D TRUS-guided biopsy [1, 5, 11], additional intra-procedural images
have been obtained using the probes with enhanced functionality (the system described in
Baumann et al. [1] requires 0.5–5s per temporal frame of acquisition) or could potentially be
obtained via the rotation of a tracked TRUS probe prior to each biopsy (the systems described in
Xu et al. [5] and De Silva et al. [11] require ~10s for a full 3D TRUS acquisition). Whereas the
former approach allows for more convenient acquisition of multiplanar images, the latter
approach permits the use of widely available conventional 2D TRUS probes in systems that
provide 3D TRUS guidance (e.g., by retrofitting, as in [3]), lowering the cost barrier to entry into
3D TRUS-guided biopsy and leveraging the physician’s investment in existing 2D ultrasound
machines. For example, Xu et al. [5] proposed a method of incorporating additional 3D
information by selecting frames with the largest separation in translations and rotations in the
out-of-plane directions using the probe’s tracking information from the set of live 2D TRUS
frames prior to targeting. This approach uses the natural motion of the handheld probe over a
short time period prior to biopsy to acquire additional planes. As another example, the
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mechanical system in Bax et al. [3] permits acquisition of additional imaging planes via the
rotation of the tracked TRUS probe. This system provides mechanical stabilization of the probe
(including optional mechanical locking of all joints, permitting only axial probe rotation), which
in principle could result in reduced prostate motion during acquisition.
The co-registration to compensate for prostate motion could be improved further by
applying a subsequent non-rigid refinement after the rigid registration, thereby compensating for
the prostate deformation caused by the variability in TRUS probe pressure. However, this
clinical application requires high-speed registration; the higher degrees-of-freedom of a non-rigid
transformation render high-speed registration very challenging. The FRE calculated using
manually identified intrinsic fiducials yields the error after an optimal rigid registration. The
FRE provides information about the room for improvement that may be obtained from a nonrigid registration, to shed light on the potential return on investment of effort in development of
high-speed non-rigid image registration algorithms for this clinical procedure. We calculated an
overall RMS ± std FRE of 1.2 ± 0.6 mm, which indicates that an optimal rigid alignment could
achieve a clinically desirable level of accuracy (i.e., < 2.5 mm RMS error [23]), possibly
eliminating the need to implement a more time-consuming non-rigid registration algorithm. Our
results show that the TRE values approached the FRE when including 3D intra-procedural
imaging during registration. Moreover, previous work [1, 22] suggests that non-rigid registration
yielded RMS TRE improvements < 0.6 mm when using intra-procedural 3D TRUS images.
Therefore, the use of intra-procedural 3D TRUS imaging with rigid registration seems to provide
a larger incremental benefit than the use of non-rigid registration.
The development of image registration methods to compensate for motion could have
applications in other 3D guided diagnostic and therapeutic interventional procedures [24, 25].
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Hungr et al. [25] describe a 3D ultrasound robotic prostate brachytherapy system that utilizes
motion compensation algorithms previously validated for biopsy guidance. The limited
anatomical context available in single-plane 2D intra-procedural images could challenge the
accuracy of co-registration with 3D pre-procedural images in many other interventional
applications. Uneri et al. evaluated the effect of dual projection view angles on 3D-2D
registration accuracy of CT and x-ray projection images for surgical guidance. Zvonarev et al.
[26] and Fallavollita et al. [27] described multiple 2D plane-3D registrations related to lung and
prostate brachytherapy. The methods described in this paper could have relevance in developing
and evaluating techniques to improve registration accuracy and robustness in such interventional
applications requiring rapid, robust registration by acquiring intra-procedural 3D imaging
efficiently, only when necessary.

4.4.1 TRE for different fixed image configurations
The TREs for bi-planar registrations shown in Figure 4.6 do not indicate substantial variability in
accuracy for the different angles between the two planes tested for those three fixed image
configurations (i.e., 𝐼0,45 , 𝐼0,135 , 𝐼0,90 ). The acquisition of a partial volume up to the angle of
rotation with a conventional tracked monoplanar probe may support more accurate motion
compensation than acquiring a single additional plane. Consequently, that approach could result
in more robust registrations than with a probe that simultaneously acquires dual orthogonal
planes, at the cost of extra time for rotational acquisitions.
According to the 𝑇𝑅𝐸0 distribution in Figure 4.6, 63% of the registrations have a TRE <
2.5 mm when using a single 2D TRUS image as the fixed image configuration. Figure 4.8 shows
𝑖𝑗

𝑖𝑗

the histogram of distribution of TRE improvements calculated as 𝑇𝑅𝐸0 − 𝑇𝑅𝐸0−179.
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According to this distribution, the improvements were less than 1 mm in 56% of all registrations
and were less than 2.5 mm in 87% of the registrations. This suggests that although 3D
information improved the accuracy and robustness of the registration, in the majority of the cases
the error when using a single 2D TRUS plane was within a clinically acceptable range [23] or the
improvements were not substantial when additional planes were included in the registration.
Intra-procedural detection of misregistration by the operator could direct the efficient use of 3D
image acquisition only for the subset of cases where this is beneficial.

4.4.2 TRE for base, mid-gland and apex regions
The analysis of TRE separately in the different sextant regions indicated that the base and apex
regions were more challenging for the registration algorithm to compensate when only using a
single 2D TRUS image, as compared with mid-gland regions. The additional 3D TRUS
information provided during registration was generally more beneficial in the base and apex
regions, yielding higher comparative accuracy improvements as shown in Table 1.2. When the
TRUS probe is positioned near the edge of the gland at the base or apex, the resulting transverse
2D views contain minimal prostate anatomy, which may not be sufficient to unambiguously coregister with the pre-acquired baseline 3D TRUS image. In order for the image-based
registration to be successful in such challenging cases, it is reasonable to expect that the image
content needs to capture richer contextual information, which can be achieved through oblique
2D views or 3D partial volumes.

4.4.3 Limitations
The registration error (TRE) measurements in this paper were made using manually identified
intrinsic fiducial landmarks within the prostate. Therefore, the TRE measurements are limited
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by the fiducial localization error (FLE) in 3D TRUS images, which were measured to be 0.21
mm in a previous study [22] involving 3D TRUS images. Fiducials were identified in baseline
and sextant 3D TRUS images, irrespective of the planes used for registration in different fixed
image configurations. Therefore, when using fewer planes than the complete 3D TRUS image,
the registration algorithm lacks complete information to calculate the optimal rigid transform for
the identified fiducials. While rigid motion of the prostate was assumed, any presence of nonrigid motion would challenge the ability of the registration algorithm to reach the ground truth
measured by the identified fiducials using fewer image planes. FRE, calculated as the lowest
possible error after applying a rigid transformation, is reflective of the magnitude of non-rigid
deformation of the prostate. Our results show that TRE approaches FRE when increasing the
amount of intra-procedural 3D-TRUS image information during registration. The remaining
difference between the FRE and 𝑇𝑅𝐸0−179 could possibly be attributed to the FLE and the
vulnerability of the registration optimizer in converging to local optima even when using full 3D
TRUS images.
The results presented in this paper are applicable to biopsy systems that utilize 3D
guidance (e.g., Artemis [Eigen, Grass Valley, CA, USA], UroNav [In Vivo, USA], Urostation
[Koelis, Grenoble, France], BiopSee [Pi Medical, Athens, Greece], Virtual Navigator [Esaote,
Italy], Real-time Virtual Sonography [HI RVS] [Hitachi, Japan]). Furthermore, in our study, the
3D TRUS images were acquired using a manually rotated, tracked, and mechanically stabilized
2D TRUS probe.
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4.5 Conclusion
In 3D TRUS-guided biopsy, accurate and rapid registration of live intra-procedural images to a
pre-acquired 3D TRUS image is necessary to minimize targeting errors. Intra-procedural 3D
TRUS information supports robust convergence of the registration algorithm to more accurate
solutions while compensating for motion. Intra-procedural 3D TRUS information could be
acquired either using probes with enhanced functionality (multi-planar or 3D probes) or by axial
rotation of a tracked conventional 2D TRUS probe. The acquisition of a partial volume up to the
angle of rotation supported more accurate motion compensation than acquiring bi-plane
configurations. The results are helpful for devising mechanisms for motion compensation by
taking advantage of intra-procedural 3D image acquisitions, considering the tradeoff of time,
probe cost, and accuracy of motion compensation. In 3D TRUS-guided biopsy systems, 3D
intra-procedural image acquisitions help to achieve a robust registration that could improve the
needle targeting accuracies to meet the clinical demands of such systems.
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Chapter 5.
Robust 2D-3D registration optimization to motion
compensation using learned prostate motion data
5.1 Introduction
In this chapter, we describe and evaluate a 2D-3D TRUS registration that incorporates
knowledge of prostate motion characteristics into the optimization process in order to improve
registration accuracy and robustness. Although 3D intra-procedure image acquisitions could help
to improve the robustness of the registration algorithm as described in the previous chapter, it is
faster, more economical and less cumbersome to acquire live 2D TRUS images and to use them
in registration for motion compensation during the procedure. A robust 2D-3D registration
algorithm would combine the advantages of more convenient live 2D TRUS acquisitions during
the procedure with the improvements in motion compensation accuracy and robustness.
Multiple algorithms have been proposed [1-4] to perform software-based motion compensation
by registering intra-procedural TRUS images to an initially acquired 3D TRUS image. The
system proposed in [3] used TRUS images acquired from a 3D TRUS probe to perform imagebased tracking to compensate for motion. Xu et al.[1] performed the registration after initializing
several previous 2D TRUS frames in a 3D coordinate system using the transformations provided
by a magnetically tracked probe. We previously [2] proposed a 2D-3D registration method using
an initialization provided by a mechanically-tracked probe. The registration needs to be
performed in a transformation space of, at minimum, 6 dimensions (for rigid registration), and
the non-convexity of the objective function in the search space can drive the optimizer to local
optima. The methods in [1, 2] rely on some initialization mechanism and then optimize an
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image-based, non-linear cost function using a local optimization technique whereas in [3] an
initial global search mitigated local optima in the subsequent Powell-Brent search. While 2D-3D
registration using a conventional real-time TRUS probe could be more challenging than 3D-3D
registration [3] using a 3D TRUS probe, motion compensation with low inter-patient registration
error variability and increased robustness is vital for successful clinical integration. In this work,
we investigated whether, in a 2D-3D registration problem, the learned characteristics of motion
induced at different probe positions for prostates can be used to overcome local optima and drive
the optimization to converge to the desired solution.
Statistical representations of high-dimensional transformations have been used to learn
prostate deformations to improve MR-TRUS registration [5, 6]. However, statistical analyses
have been previously performed using finite element analysis (FEA)-simulated motion in 3D
TRUS images [5] and phantoms [6] whereas this work utilized statistics of observed motion in
actual prostate interventions. Outside of the prostate TRUS context, statistical representations of
high-dimensional transformations have been previously used to learn or constrain both rigid and
non-rigid registrations [7-9]. Strategies have also been proposed to improve the robustness of
optimization techniques during registration [10].
The objective of this work is to utilize the statistics of observed prostate motion data to
improve the robustness of registration optimization. In this work, we analysed the prostate
motions observed from 29 patients to learn a model representing the characteristics of prostate
motion. We then incorporated the parameters from this model to improve the robustness of the
registration optimization. The rest of the paper describes our approach to learning of prostate
motion characteristics and our adaptation of that learned statistical information to improve the
search for the optimum of the cost function.
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5.2 Materials and Methods
5.2.1 Data acquisition
The images were acquired from 29 patients as part of a larger human subjects research ethics
board approved MRI-3D TRUS fusion biopsy study of our institution. Using a mechanicallyassisted biopsy system described in Bax et al. [11], we acquired 3D TRUS images with an endfiring 5-9 MHz TRUS transducer probe (Philips Medical Systems, Seattle, WA) during human
clinical biopsy procedures. In addition to the baseline 3D TRUS image (𝐼𝐵 : ℝ3 → ℝ) that would
usually be acquired following the standard operating procedure for the system in [11], we
acquired six other 3D TRUS images (𝐼𝑃𝑖 : ℝ3 → ℝ where 𝑖 ∈ {1,2, . .6}) after positioning the
TRUS probe at the corresponding standard sextant systematic biopsy locations. Figure 5.1 shows
the relative bilateral sextant probe positions in base, mid and apex regions of the prostate. The
mechanical encoders attached to the TRUS probe tracked the 3D position and orientation of the
probe in real-time, which enabled the transformation of 3D volume to a common world
coordinate system. Images were acquired from 29 patients following the protocol described
above with 7 3D TRUS images per patient, for 203 images in total. During 2D-3D registration a
transverse 2D slice (𝐼𝑝𝑖 : ℝ3 → ℝ) was obtained from 3D TRUS images at each sextant probe
position and registered to the baseline 3D image.
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Figure 5.1: Probe positions during image acquisition shown relative to (a) coronal view (b) axial view.

5.2.2 Modeling rigid prostate motion
Corresponding fiducial pairs of anatomically homologous points (corresponding, naturallyoccurring micro-calcifications) were manually identified in 3D TRUS image pairs consisting of
(𝐼𝐵 , 𝐼𝑃𝑖 ) for each patient. We denote the fiducials identified in the baseline image as 𝑓𝐵 ∈ ℝ3 and
those identified in the image with probe position 𝑖 for that patient as 𝑓𝑃 𝑖 ∈ ℝ3 . For each patient
𝑗, we computed the optimal rigid alignment using the identified fiducials that defines the best six
∗
parameter rigid transformation vector 𝑥𝑖𝑗
(henceforth referred to as a motion vector) out of all the

possible rigid transformation vectors 𝑥𝑖𝑗 ∈ ℝ6 according to,
𝑀
∗
𝑥𝑖𝑗

=

arg min ∑ (𝑓𝑃𝑚𝑖 ⨂
𝑥𝑖𝑗
𝑚=1

(
𝑥𝑖𝑗 −

𝑓𝐵𝑚 ⨂

yij )

2

(5.1)

where 𝑦𝑖𝑗 : ℝ3 → ℝ3 is the transformation obtained from tracking the probe (which maps the 3D
image to the world coordinate system) and operator ⨂ denotes the application of a rigid 3D
transform to the fiducial location. 𝑀 is the number of fiducial pairs identified per registration.
Six such fiducial-based registrations per patient were performed, one for each sextant location. A
total of 1003 fiducial pairs were identified with an average of 6 fiducial pairs per registration. It
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is important to note that these fiducial pairs were identified only to measure and characterize
prostate motion; the registration algorithm described in the following sections is fully imagebased and does not rely on the identification of fiducial landmarks.
We analysed the estimated motion vectors to determine a suitable model to represent the
∗
observed data. Each vector 𝑥𝑖𝑗
, measured using manually identified fiducials, can be represented

as a point in the six-dimensional (6D) rigid transformation space. Different patient and probe
positions generate a cloud of points in the 6D space representing the motions observed in the
data set. We assumed that prostate motion has some characteristic patterns, since the patient
positioning constrains the motion in certain directions within the biopsy set-up and the
transrectal access to the prostate constrains the motion of the TRUS probe during navigation.
We analysed the distribution of the resulting point cloud in the 6D space to understand the
patterns related to prostate movement during the biopsy procedure. During our initial analysis,
the point distribution failed an uni-modal Gaussianity test (Kolmogorov-Smirnov test, p <
0.001). Assuming the point distribution is multi-modal, we performed an unsupervised
clustering of the data by fitting a mixture-of-Gaussians (MoG) model using expectation
maximization (EM) algorithm [12]. The number of clusters is an important parameter that needs
to be provided as input to the EM algorithm. We used the gap statistic [13] to calculate a
reasonable estimate to this parameter. We represented the estimated distribution of motion
vectors as
𝑇

(

ℱ(𝑥) = ∑ 𝒩(𝑥̅𝑡 , 𝐶𝑡 )
(5.2)

𝑡=1

where 𝑥̅𝑡 is the mean of the cluster 𝑡 and 𝐶𝑡 is the covariance matrix of the Gaussian distribution
𝑡.
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5.2.3 Robust search strategy during registration optimization
Equipped with a MoG model that represents prostate motion characteristics, we explored more
effective ways to traverse the transformation space during registration optimization. The class of
optimization algorithms having the quadratic convergence property assume a quadratic model of
the form 𝒢(𝑥) = 𝑥 𝑇 𝐴𝑥 + 2

𝑇

𝑥 + 𝑐 in the local neighborhood of the optimum [14]. If this

assumption is met within reasonable bounds, these algorithms can find the function optimum
within a finite number of function and/or derivative evaluations. This is a desirable property for
registration problems requiring rapid convergence.
To achieve quadratic convergence, some algorithms attempt to evaluate or approximate
the Hessian matrix, 𝐴, in the quadratic model, 𝒢(𝑥), that captures the second order properties of
the function [14]. Direction set methods like the conjugate gradient method [15] and Powell’s
method [16] approximate a set of directions conjugate to 𝐴 without explicit knowledge of the
function 𝒢(𝑥). Improving (i.e., decreasing) the condition number of 𝐴 (the ratio between the
largest and smallest eigenvalues of 𝐴) has been demonstrated to improve the convergence
properties of such algorithms [17]. This approach scales the search space to increase the isotropy
of a multi-dimensional objective function, which is helpful for the optimizer to take
approximately equidistant steps during the line searches performed in a set of conjugate
directions. Figure 5.2 illustrates the effect of improving the condition number in a twodimensional hypothetical function with example line search direction shown in a red arrow from
the starting location depicted by the red circle.
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Figure 5.2: Diagram depicting the improvement (i.e., decrease) of the condition number (𝜆2 /𝜆1 ) of a 2D objective
function by scaling the search space according to the eigenvalues (𝜆2 , 𝜆1 ) of the matrix 𝐴 of the objective function.
(a) Initial search space of the objective function. (b) Situation after the search space is scaled according to 𝜆2 , 𝜆1 .
Black ellipsoids/circles show the function iso-contours, with larger circles/ellipses indicating less optimal values of
the objective function. The red circle shows an example initial search location and the red arrow shows a typical
Powell’s method initial search direction.

Powell’s method is a derivative-free optimization method that has quadratic convergence
properties. For a 𝐷-dimensional quadratic function, line minimizations along 𝐷 linearly
independent, mutually conjugate directions will exactly find the function minimum. Powell's
algorithm determines a set of such directions after initialization with the columns of any 𝐷 × 𝐷
orthogonal matrix. For non-quadratic functions, which are usually encountered in image
registration problems, repeated cycles of 𝐷 line searches are done iteratively until convergence.
Usually this initialization is performed using the column vectors of an identity matrix [18].
(
2

𝐶𝑡 = 𝑈Λ 𝑈
(5.3)
1

𝒩(𝑥̅𝑡 , 𝐶𝑡 ) = 𝑥̅𝑡 + 𝒩(0, 𝐶𝑡 ) = 𝑥̅𝑡 + 𝐶𝑡 2 𝒩(0,1)
2

= 𝑥̅𝑡 + (𝑈Λ

1
𝑈)2 𝒩(0,1)
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(
(5.4)

𝑈 denotes the matrix containing the principal directions and Λ is the diagonal matrix containing
the eigen values.
Each cluster in the MoG model can be represented by its mean 𝑥𝑡 and covariance matrix
𝐶𝑡 . The covariance matrix captures information related to the second order properties of the
motion vector distribution in the 6D space within the cluster. The eigen decomposition of 𝐶𝑡
yields an orthogonal matrix 𝑈 as shown in Equation 5.3 that contain the principal directions of
maximal inter-patient variability of the observed motion vectors in the cluster 𝑡. The eigenvalues
of the matrix 𝑈 (contained in the diagonal elements in the matrix Λ) can be used to scale the
search along corresponding principal directions contained in 𝑈. Such an approach would scale
the search space to improve the isotropic properties of the distribution of previously observed
motion vectors in that cluster. Figure 5.3 illustrates how this scaling helps to guide the initial line
searches towards the directions where we have already observed function optima. Thus, the
principal directions given by the matrix 𝑈 after being appropriately scaled by its eigenvalues
could provide a good initialization for the Powell’s direction set method. This is in principle
different from the approach of scaling the search space to improve the condition number of the
Hessian matrix, 𝐴 in that we do not explicitly learn properties related to 𝐴 for the functions in the
observed data set. We instead use the locations within the search space where the previous
functions similar to 𝒢(𝑥) have converged. We adopted this approach since we observed that
characteristics of the Hessian matrices for different objective functions across the patients in the
data set seem to be arbitrary, yet we were able to generate a model that represent the
characteristics of the locations of the function optima.
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Figure 5.3: Scaling the search space according to the eigen values (𝜆2 , 𝜆1 ) of the covariance matrix 𝐶𝑡 of the
observed motion vectors. (a) Initial distribution of the motion vectors in the search space. (b) After the search space
is scaled according to 𝜆2 , 𝜆1 in the principal directions. The points representing the observed motion vectors (i.e.,
objective function optima). The red circle shows an example initial search location and the red arrow show a typical
Powell’s method initial line search direction.

We developed a two-stage search strategy with the objective of improving the robustness
of registration optimization. In order to mitigate the optimizer finding local optima, a multi-start
search was devised as the first step. The cluster means 𝑥𝑡 in the MoG model were used to
initialize the multiple start positions in the search space. Within each cluster, we optimized the
normalized cross-correlation (NCC) image similarity metric using Powell’s direction set method.
Powell’s method was initialized with the principal directions in the matrix 𝑈 obtained from eigen
decomposition of 𝐶𝑡 as in Equation 5.3. The search along these directions was scaled using the
eigenvalues in Λ, by setting the step size proportional to those eigenvalues during the line
direction searches. This effectively scales the initial search directions such that the previously
observed motion vectors are approximately isotropically distributed within the search space.
During the second step of our search strategy, we selected the cluster that yielded best metric
value after one iteration and continued the search until convergence. While the rapid
convergence property of Powell’s method is helpful in selecting the optimal cluster after a small
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number of iterations, one iteration was empirically found to provide an accurate selection of the
optimal cluster. Thus, the search strategy adds only a finite number of extra line minimizations
to the standard Powell’s method.

5.2.4 Experiments
For the 29 patients, we performed 174 registrations in total with 6 registrations per patient when
the probe was positioned at each sextant biopsy location. We validated the registrations using the
manually identified fiducials for each image pair and calculated the root mean square (RMS)
target registration error (TRE). We used leave-one-out cross-validation approach; fiducials in
test image of a given patient were excluded in calculating the model and search directions for
that patient. To compare the results, we performed registrations using Powell's method as in [2,
18] henceforth referred to as the initial method, and using the new version described in this
paper and calculated the TREs separately for each method.

5.3 Results
Multiple trials evaluating the gap statistic yielded a mode of 4 as the number of clusters (𝑇) in
our motion vector data. Table 5.1 shows the RMS TREs and standard deviations (std) of errors
before registration, after registration with the initial method, after registration with the new
optimization method using the MoG model, and fiducial registration errors (FRE). The FRE
calculated using the fiducials used during validation provides a lower bound on the TRE that can
be obtained after performing a rigid registration. Figure 5.4 shows distributions of TREs before
and after registration with the two methods. With the new optimization method, we observed a
statistically significant difference in TRE (paired t-test rejected the null-hypothesis with p <
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0.001) compared to the initial method indicating an improvement in accuracy and robustness of
the registration. After using learned optimization method, the average number of iterations
required for convergence decreased from 4.9 to 3.3. Using a GPU accelerated implementation for
NCC calculation (NVIDIA GTX 580 GPU card and Intel Xeon 2.5 GHz processor), the updated
method takes approximately an additional 1.1 s. However, multi-start strategy at different motion
clusters can be executed in parallel to further reduce execution time during registration. Figure
5.5 contains five representative example images, depicting the visual alignment qualitatively
before and after registration with the methods described in the paper.
Table 5.1: Comparisons of performance before and after registration with new and initial methods, and FRE.
RMS TRE (mm)
std (mm)
Avg no of iterations
Execution time (s)

Before
4.95
2.37
n/a
n/a

70

Initial method
3.12
1.70
4.9
1.7

New method
2.33
1.12
3.3
2.8
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1.15
0.57
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Figure 5.4: TRE histograms (a) TRE before registration. (b) TRE after registration without using learned prostate
motion characteristics. (c) TRE after registration using the proposed method.
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Figure 5.5: Images before and after registration for 5 patients. Top row: extracted 2D images (𝐼𝑝𝑖 ). Middle row:
corresponding frames from the registered 𝐼𝐵 . Bottom row: corresponding frames before registration obtained from 𝐼𝐵
after tracking the probe.

We analysed the robustness of the new method in comparison to the initial approach by
evaluating the performance of the registration algorithms relative to the smallest clinically
significant tumours, having a volume greater than 0.5 cm3 according to Epstein et al. [19]. To
ensure the successful sampling of tumours with 5 mm radius, we examined cases that resulted
with TRE >5 mm after the initial method to see how the accuracy has improved with the new
method. Table 5.2 compares the performance of that subset of registrations (TRE > 5mm with
the initial method) with the two different methods.
Table 5.2: Comparison of performance for registrations with TRE >5 mm with the initial approach.

TRE (initial) (mm)
TRE (new) (mm)
TRE(initial)-TRE (new) (mm)

Registrations with TRE > 5mm with the initial method
Mean
std
Median
Min
Max
6.70
1.71
5.96
5.00
10.84
3.25
1.39
2.77
1.54
6.30
3.45
2.49
2.69
-0.13
8.30
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Figure 5.6: Comparisons of TREs in the two methods. The gray circles indicate biopsies for which the TRE from
the initial method was <= 5 mm. The coloured symbols indicate biopsies for which the TRE from the initial method
was > 5 mm. The coloured squares indicate TREs from the initial method, and the coloured triangles indicate TREs
from the new method. Upward-pointing triangles show cases where the TRE from the new method was larger than
the TRE from the initial method. Downward-pointing triangles indicate cases where the TRE from the new method
was smaller than the TRE from the initial method. A symbol of a given colour corresponds to a specific registration.

With the initial method, the mean of all TREs > 5 mm was 6.7 mm. With the new
method, the mean TRE for these same patient cases was reduced to 3.25 mm; a reduction of 3.45
mm. Figure 5.6 graphically illustrates the improvement in TRE given by the new method.
According to this figure, we can see that in all but two cases the new method improved over the
initial method, for cases where the initial method produced a TRE of > 5 mm. We can also
observe a shift of the gray circles in the downward direction with only a couple of circles lying
above the 5 mm threshold line.
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Figure 5.7: Comparison of NCC at convergence in the two methods. The gray circles indicate biopsies for which
the TRE from the initial method was <= 5 mm. The coloured symbols indicate biopsies for which the TRE from the
initial method was > 5 mm. The coloured squares indicate NCCs from the initial method, and the coloured triangles
indicate NCCs from the new method. Downward-pointing triangles show cases where the NCC from the new
method was smaller than the NCC from the initial method. Upward-pointing triangles indicate cases where the
NCC from the new method was larger than the NCC from the initial method. A symbol of a given colour
corresponds to a specific registration.

Figure 5.7 graphically illustrates the differences in NCC at convergence between the
initial method and the new method. We observed that in all but one case the new approach to
optimization based on learned motion data converged to a higher NCC than the initial method.
We can also observe that the grey circles have an upward shift with the new method. The
improved NCCs at the time of convergence indicate that the optimizer has been successful in
finding desired solutions in the objective function space.

5.4 Discussion
We observed an improvement in the 2D-3D registration performance after incorporating learned
prostate motion characteristics into the algorithm. Using the initial method, the 2D-3D
registration had a TRE > 5 mm for nearly 10% (9.25%) of the biopsies in our sample. If 9.25%
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of all biopsies are guided based using motion correction with TRE > 5 mm, then on average
every patient undergoing 12-core extended extant biopsy will have one or more biopsies taken
with sufficient motion correction error such that a tumour of clinically significant size may be
missed. Using the new method, the 2D-3D registration had a TRE > 5 mm for 1.16% of the
biopsies in our sample. If 1.16% of all biopsies are guided based on using motion correction with
TRE > 5 mm, then on average 1 out of every 86 biopsies will be taken with sufficient motion
correction error such that a tumour of clinically significant size may be missed. Thus, on
average, one out of every eight patients undergoing 12-core extended sextant biopsy will have
one or more biopsies taken with sufficient motion correction error such that a tumour of
clinically significant size may be missed.
∗
The calculation of the best rigid transformations (𝑥𝑖𝑗
) to characterize prostate motion is

limited by the operator's ability to accurately identify and correspond fiducial locations. Since we
considered the transformations given by the manually identified fiducials as the ground truth,
fiducial localization error limits our ability to measure a registration algorithm’s in improvement
of accuracy. Furthermore, any non-rigid deformation of the prostate would challenge our
assumption of rigid motion. The ability of the registration to match the best rigid alignment
calculated based on fiducials identified throughout the prostate could also be limited by the fact
that we are restricted to using a single 2D slice during registration. In such a situation, non-rigid
deformation might pose an additional challenge for the algorithm to estimate the overall rigid
motion of the prostate by only using the image information in the 2D plane.
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5.5 Conclusions
In this paper, we demonstrated that the learned prostate motion directions can be used to improve
2D-3D TRUS registration optimization, which has the potential to improve the clinical outcomes
of MRI-3D TRUS fusion biopsy. Our results indicate that we can improve the accuracy and
robustness of the algorithm, at the cost of 1-2 s of additional execution time. This would help 3D
TRUS-guided biopsy systems to achieve clinically desired level of accuracy in needle targeting.
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Chapter 6.
Conclusions and Directions for Future Work
6.1 Conclusions
The work in this thesis intends to improve needle targeting accuracy of 3D TRUS-guided
biopsy systems. Towards achieving this goal, the errors due to patient and prostate
motion during the procedure were quantified and methods were developed to compensate
for the intermittent motion via rapid image-based registration techniques. The methods
developed in this work have been successfully integrated into the mechanically assisted
3D TRUS-guided biopsy system [1] previously developed in our lab and are currently
being used in human clinical biopsy procedures as part of an ongoing study. The work
was divided into four chapters according to the objectives listed in the Section 1.9, and
the conclusions of each are discussed in the following.
In Chapter 2, we used non-rigid registration of 2D TRUS images to quantify the
deformation that occurs during the needle insertion and the biopsy gun firing procedure
and compared this effect in biopsies performed using a hand held TRUS probe with those
performed using mechanically assisted 3D TRUS-guided biopsy system [1]. While such
errors had been previously quantified in prostate brachytherapy applications where
accurate needle guidance is necessary for radioactive seed implantations, we investigated
this problem in the context of 3D TRUS-guided biopsy. Prostate deformation during
needle insertion can cause target misalignments after the physician has successfully
aligned the biopsy needle trajectory with the target locations in preparation for taking a
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tissue sample. Since the needle insertion and biopsy gun firing happen in a rapid
progression within a sub-second interval, the targeting error due to prostate deformation
in that duration is very challenging to compensate. However, given the need to
accurately sample the smallest clinically significant tumours, it is an important
consideration when setting the design specifications for MR-targeted TRUS-guided
prostate biopsy systems. As described in Section 1.10.2, an image registration algorithm
with RMS TRE ≤ 2.3 mm is required for the central hypothesis of this work to be
confirmed, in the context of our measured tissue displacement due to biopsy needle
insertion.
In Chapter 3, we described a technique to compensate for intermittent patient and
prostate motion during biopsy, which is the central problem addressed in the work of this
thesis. Compared to the errors quantified in Chapter 2, patient motion due to discomfort
and prostate motion due to applied TRUS probe pressure caused larger target
misalignments, limiting needle targeting accuracy [2]. We developed an image-based
2D-3D registration algorithm to align live 2D TRUS images acquired during the
procedure with the baseline 3D TRUS image acquired immediately prior to performing
biopsy. The accuracy was measured by calculating the TRE using manually identified
fiducials (micro-calcifications) of the prostate. A GPU-based implementation was used
to improve the registration speed. While this showed encouraging results by achieving
statistically significant improvements in accuracy, there were some registrations with
error >5 mm and a measured RMS TRE of 3.2 mm. Therefore, methods to improve the
accuracy and robustness of this technique would be helpful to meet the clinical
requirements.
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In Chapter 4, we evaluated the utility of incorporating additional intra-procedural
3D TRUS image information in guiding registration for improved motion compensation.
The limited anatomical context available in a subset of the live 2D TRUS images might
not capture sufficient information to obtain an accurate registration with the baseline 3D
TRUS image. While 2D TRUS images are widely used for intra-procedural guidance,
some solutions utilize richer intra-procedural images such as bi- or multi-planar TRUS or
3D TRUS, acquired by specialized probes. Therefore, the impact of such richer intraprocedural imaging on displacement compensation accuracy was measured to evaluate
the tradeoff between cost and complexity of intra-procedural imaging versus improved
displacement compensation. We performed an extensive validation using baseline and
intra-procedural 3D TRUS images acquired from 29 patients. While the majority of the
registrations using 2D TRUS images provided a clinically desired level of accuracy,
intra-procedural 3D imaging helped improve the overall registration accuracy and
robustness, especially in the base and apex regions of the prostate. These results are
helpful for devising image-based registration methods and designing clinical workflow
for motion compensation in 3D TRUS-guided biopsy systems.
Towards the objective of improving the robustness of registration for motion
compensation, we investigated an alternative approach in Chapter 5 that does not require
additional image acquisitions during the procedure. Since the patient motion is
constrained while being in the left lateral decubitus positioning within the biopsy setup
and the TRUS probe motion is restricted while accessing the prostate transrectally, it is
reasonable to assume that prostate motion has some characteristic patterns. Incorporating
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information of the identified characteristic patterns of prostate motion during registration
optimization helped to improve the robustness in an effective manner.
In this thesis, we have demonstrated the use of image-based registration methods
to quantify and compensate for prostate motion during 3D TRUS-guided biopsy.
According to our hypothesis, the RMS error of the biopsy systems should be ≤ 2.5 mm in
order to accurately sample the smallest clinically significant tumours. The errors due to
prostate deformation during needle insertion and biopsy-gun firing restrict this
requirement further to 2.3 mm. Although 2D-3D registration methods described in
Chapter 3 were encouraging, with statistically significant improvements in compensating
for intermittent patient and prostate motion, methods to further improve accuracy and
robustness were needed for the successful clinical translation of this technique. Chapter 4
and 5 describe two different approaches to achieving improved registration accuracies.
The improved accuracy and robustness either by acquiring intra-procedure 3D image
information for use during registration or by improving the registration optimization
using the learned motion characteristics of the prostate have demonstrated performance
improvements in image-based registration that meet the clinical requirements for needle
targeting accuracy of the biopsy system.
Thus, the central hypothesis of this thesis is confirmed when either of the
approaches described in Chapters 4 or 5 are applied, and the choice of approach to use in
a given context may be guided by ultrasound probe/machine availability. The central
hypothesis of this thesis is not confirmed when only the approach described in Chapter 3
is applied.
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6.2 Suggestions for future work
The registration techniques developed in this work could be directly helpful in ongoing
clinical investigations related to prostate biopsy. There are other clinical applications that
require rapid registration to transform pre-procedure image information to the intraprocedure image space to improve diagnostic and therapeutic clinical outcomes in imageguided interventions. Some extensions of the work described in this thesis might lead to
applications in multiple such areas of currently active research.

6.2.1 Applications in ongoing clinical studies
Multiple clinical studies [3-5] have reported improved cancer detection rates using MRtargeted biopsy schemes. It would be interesting to investigate how the improved needle
targeting accuracy after integrating prostate motion compensation into the clinical
workflow during the procedure impact clinical outcomes of the procedure. The potential
impact in cancer detection rates could be investigated in a prospective clinical study. The
improved cancer detection rates could elevate the ability of the physician to better
differentiate between clinically aggressive and indolent tumours by strengthening the
confidence of the evidence. During prostate cancer diagnosis and patient risk
stratification, however, the current standards of interpreting biopsy results are calibrated
to the conventional random systematic biopsy schemes, which carry a higher degree of
uncertainty. The ability to accurately target suspicions foci might lead to re-visit the
current guidelines to improve the interpretation of biopsy results with more reliable
evidence of the disease at hand.
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6.2.2 Applications in other clinical procedures
The techniques developed in this thesis could have relevance in other image-guided
interventions that require fast and accurate registration to compensate for organ motion.
One such example with direct relevance to prostate cancer management is in emerging [6,
7] interventional systems developed to treat intermediate-risk prostate cancer with
localized ablation. In such systems, tumours contoured prior to the procedure need to be
detected and verified in the intra-procedure images prior to ablation. Motion correction
algorithms could be helpful to align the target regions during the procedure to improve
the accuracy of ablating the intended region and to ultimately reduce the margins ablated
around the tumour due to uncertainty. Prostate deformation could be a potential
challenge in developing such registration algorithms for some applications. For example,
during focal laser ablation [6] of tumours, intra-procedure MR images are acquired to
verify the target region. The endorectal coil used to acquire MR images could deform the
prostate differently than when it was acquired prior to the procedure for diagnostic
purposes. Non-rigid registration algorithms might be necessary to account for such
differences in deformation during the procedure after achieving a robust rigid registration
as an initial step. The techniques described in this work needs to be extended to account
for non-rigid deformations in such applications.
Ultrasound-guided interventional systems have recently been developed for tissue
ablation in kidney [8] and liver [9]. Organ motion during the procedure could limit their
accuracy in delivering the treatment to the desired region. Hence, these systems might
also potentially benefit from rapid image registration algorithms to compensate for organ
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motion. However, the characteristics of motion in the organ of interest are an important
consideration when developing registration techniques. The liver motion, for example,
could be affected primarily by the periodic breathing, since it is an organ with close
anatomical proximity to the lung. When compensating for such continuous and periodic
motion, the registration might need to be performed faster than what was required during
prostate biopsy. Efficient software code optimization and parallel implementations could
help to further improve registration times.

6.2.3 Applications in image-based tracking
Intra-procedure image tracking is an essential component when developing systems to
perform many image-guided interventions. Electromagnetic, optical and mechanical
devices are typically used to track real-time imaging devices during the procedures. Pure
image-based tracking is an alternative method that can be used to determine the position
and the orientation of the imaging device via image registration. Low cost and compact
design are the major advantages of this approach by eliminating the need for hardware
tracking devices in the system. In the experiments described in this thesis, we used the
transformation given by the mechanical tracking device to initialize the registrations. If
the registration is performed without this initialization, it has to simultaneously
compensate for motion of the prostate as well as the motion of the TRUS probe. This
would be a very challenging correspondence problem considering the limited information
available in a single plane 2D TRUS image. If the prior knowledge of the prostate
anatomy and the prostate motion can be used to provide a reasonable initialization to the
registration algorithm, that could help to make the registration problem more tractable
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when only using the image information. Technical advancements in methodology for
incorporating prior domain knowledge into the registration framework might help to
achieve accurate and robust results that would benefit the development of software-based
solutions and their widespread use for tracking purposes.
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